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The number of people affected by degenerative diseases of the retina increases notably 
due to the longer life expectancy. The weakening of the sight concerns especially older 
people, who suffer from degeneration of the retina and its retinal pigment epithelium 
(RPE) monolayer. Currently, these degenerative diseases of the retina are incurable. 
Cell transplantation of healthy RPE cells is considered to be a potential treatment for 
these diseases. Due to the unlimited self-renewal capacity and pluripotency human 
pluripotent stem cells (hPSCs) are considered as possible cell sources for transplantation 
purposes. However, the current differentiation protocols for RPE cells from hPSCs are 
inefficient and result in low yields.  
The aim of this thesis was to study whether biodegradable poly(L-lactide) 
(PLLA) microparticles and commercial biostable cellulose anion exchange 
diethylaminoethyl (DE) 53 microparticles could be exploited in increasing the efficacy 
of differentiation of hPSCs into RPE cells. In addition, the potential of the microparticle 
culture system for stem cell maintenance in feeder-free conditions was evaluated. The 
attachment and proliferation of hPSCs on microparticles were analyzed by 
immunofluorescence analysis and microscopy. The success of differentiation of RPE 
from stem cells in microparticle cultures was evaluated by inspecting the appearance of 
pigmentation in cultures as well as by investigating the expression of RPE maturation 
markers on gene expression levels by RT-PCR.  
 The PLLA microparticles did not support the attachment and proliferation of 
hPSCs in feeder-free conditions. The poor performance of PLLA particles in cell culture 
studies might be due to the hydrophobic nature of the particle surfaces. In contrast, 
hPSCs attached, proliferated and maintained their pluripotency on DE 53 particles. 
Furthermore, the hPSCs were successfully differentiated into RPE cells on these DE 53 
particles. However, the differentiation efficacy did not outperform the conventional 
differentiation protocol. 
This was the first study in which the hPSCs were successfully differentiated into 
RPE cells on microparticles. Microparticles are far from being routinely used in hPSC 
maintenance and differentiation to mature cell types. More long-term and large-scale 
studies need to be conducted in the future. Nevertheless, at the moment they seem 
appealing and promising with a possibility to grow stem cells in large-scale and cost 
effectively. The microparticle culture systems set challenges for the cell analysis due to 
their 3-dimensional structure and autofluorescence property. Therefore, novel methods 
for characterization, analysis and imaging of microparticle culture systems should be 
developed. 
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Väestön ikääntyessä myös rappeumasairauksien esiintyvyys lisääntyy. Verkkokalvon 
ikärappeumasta kärsivät yleensä ikääntyneet yli 60-vuotiaat ihmiset. Verkkokalvon 
ikärappeumassa verkkokalvon pigmenttiepiteeli (RPE) on vaurioitunut. Tällä hetkellä 
ikärappeumaan ei ole parannuskeinoa, ja olemassa olevat hoidot vain hidastavat 
sairauden etenemistä. Terveiden RPE-solujen siirtoa vaurioituneelle alueelle pidetään 
lupaavana hoitokeinona verkkokalvon ikärappeumaan. Ihmisen erittäin monikykyiset 
kantasolut (hPSCs) ovat jatkuvasti jakaantuvia soluja, joilla on kyky erilaistua useiksi 
solutyypeiksi. Kuitenkin näiden solujen erilaistaminen RPE-soluiksi nykyisillä 
menetelmillä on tehotonta, ja erilaistuksen saannot ovat pieniä. 
 Tämän diplomityön tavoitteena oli tutkia voidaanko biohajoavia poly(L-laktidi) 
(PLLA) ja kaupallisia hajoamattomia DE 53 mikropartikkeleita hyödyntää RPE-solujen 
erilaistuksen tehostamisessa kantasoluista. Myös mikropartikkeleiden soveltuvuus 
kantasolujen ylläpitämiseen ilman ihmisen esinahan fibroblasteja tukisoluina oli 
tutkimuksen kohteena. Kantasolujen kiinnittymistä ja lisääntymistä mikropartikkeleille 
analysoitiin immunofluoresenssitekniikalla ja mikroskopoimalla. Solujen erilaistumista 
mikropartikkeleilla seurattiin tarkkailemalla pigmentoituneiden solujen ilmestymistä 
viljelmiin, sekä kypsien RPE-solujen markkereiden ilmaantumista geenitasolla RT-
PCR:llä. 
 Tutkimuksessa selvisi, että biohajoavat PLLA-mikropartikkelit eivät tue hPSC-
solujen kiinnittymistä ja lisääntymistä. Tämä johtuu todennäköisesti PLLA-
partikkeleiden hydrofobisesta pinnasta. Sitä vastoin hPSC-solut kiinnittyivät, 
lisääntyivät ja pysyivät monikykyisinä kaupallisilla DE 53-partikkeleilla. Lisäksi DE 
53-partikkelit tukivat hPSC-solujen erilaistumista RPE-soluiksi erilaistuksen 
tehostustutkimuksessa. Erilaistus mikropartikkeliviljelmässä ei ollut kuitenkaan 
tehokkaampaa kuin perinteisessä käytössä olevassa erilaistusmenetelmässä.  
 Tämä tutkimus oli tietämämme ensimmäinen, jossa hPSC-soluja erilaistettiin 
onnistuneesti RPE-soluiksi mikropartikkeliviljelmässä. Perusteellisempia pitkän 
aikavälin tutkimuksia mikropartikkeleiden soveltuvuudesta kantasolujen viljelyyn ja 
erilaistukseen tulisi tehdä jatkossa. Kantasolujen kasvatus mikropartikkeliviljelmissä 
mahdollistaisi toimiessaan näiden solujen laajamittaisen tuotannon 
kustannustehokkaasti. Tällä hetkellä suuri haaste tutkimuksessa on solujen analysointi 
mikropartikkeleiden vahvan autofluoresenssin ja kolmiulotteisen rakenteen vuoksi. 
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1. INTRODUCTION 
 
Vision is a prerequisite for a good life quality and independency. Today, there are 
approximately 180 million visually impaired persons in the world. Approximately 45 
million of these are completely blind, and the rest are more or less weak sighted. The 
weakening of the sight concerns especially older people, who suffer from degeneration 
of the retina and its retinal pigment epithelium (RPE) monolayer. As the population is 
getting older due to the higher life expectancy, the number of people dealing with 
degenerative diseases of the retina, increases notably. (Finnish Federation of the 
Visually Impaired 2011) 
 In many cases of retinal degeneration, the inner layers of the retina, associated 
neural and glial cells and the optic nerve maintain their functionality and organized 
structure for a period of time. Therefore, by introducing a population of healthy cells, 
with the capacity to promote photoreceptor survival, into the damaged subretinal area, 
the vision could be preserved. For instance, age-related macular degeneration (AMD) is 
the most common cause of blindness among people over 60 years of age. Currently, 
there is neither prophylactic treatment nor cure for this degenerative disease. 
Transplantation of healthy RPE cells is considered as a very potential future therapy 
method for retinal degenerative diseases such as AMD. (Gehrs et al. 2006; Hynes et al. 
2010) 
 The effectiveness of the cell transplantation to treat degenerative retinal diseases 
has been already proven with autologous cells. However, there are not usually enough 
healthy cells left in degenerative retinal disease patients for transplantation purposes. 
(Binder et al. 2002) Therefore, human pluripotent stem cells (embryonic and induced 
stem cells, hPSCs) are considered to be potential cell sources for transplantation 
purposes. Nevertheless, traditional culture methods of hPSCs are impractical or unable 
to produce necessary scale-up of the cells for transplantation and research purposes. 
(Martin et al. 2011; Rowland et al. 2011) The currently used protocols for RPE cell 
differentiation from stem cells are based on spontaneous differentiation and result in 
low yields (Klimayanska et al. 2004; Rowland et al. 2011). Therefore, the search for 
more effective culture systems and differentiation protocols arouse huge interest among 
the field of ophthalmology and tissue engineering.   
 Diameter of microparticles is in microscale. These small particles have been 
used for cell culture of anchorage dependent cells for decades with great success (van 
Wezel 1967; Martin et al. 2011). Microparticles offer great advantages over 
conventional 2-dimensional (2D) culture systems such as a larger surface area. In 
addition, they overcome the need for large quantities of culture media, space expense, 
inefficient gas-liquid oxygen transfer, presence of concentration gradients and 
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difficulties in monitoring and control. The utility of microparticles in cell culture has 
been shown with mature cells, but modifying microparticle culture system for hESCs is 
more difficult. (Martin et al. 2011; Sun et al. 2011) 
 The aim of this thesis was to study if self-prepared biodegradable microparticles 
and commercial biostabile microparticles could be used for increasing the efficacy of 
differentiation of hPSCs into RPE cells. In addition, the potential of the microparticle 
culture system for stem cell maintenance in feeder-free conditions was evaluated.  In 
this study, biodegradable poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) 
(PLLA) microparticles were prepared by a single emulsion-based method. The 
characteristics and performance of these self-prepared particles in cell culture and 
differentiation experiments were compared to commercial cellulose anion exchange 
diethylaminoethyl (DE) 53 microparticles.  
 This thesis consists of a theoretical and an experimental part. In the theoretical 
part, background information about the structure and functions of RPE and retinal 
degenerative diseases are introduced. In addition, the potential of hPSCs as a cell source 
for tissue engineering applications, and the differentiation protocols for RPE from stem 
cells are illustrated. Furthermore, the concept of microparticles, their preparation 
methods and current use in cell culture and tissue engineering are presented. In the 
experimental part, the course of the study from particle preparation to differentiation of 
hPSCs on microparticles is reported in detail. Finally, the results of these experiments 
are reported, discussed and concluded. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
THEORETICAL PART
2. RETINA 
The sight is vital for our understanding of the surrounding environment. In fact, the eye 
contains approximately 70% of the sensory cells of the body. The eye is a complex 
structure which consists of epithelial, mesenchymal, connective and neural tissue. It is a 
highly specialized organ capable of photoreception, a process which involves the 
conversion of light energy into nerve action potentials. (Haug et al. 1999; Young et al. 
2006) In next chapters, the structure of the eye and the retina are introduced with special 
focus on the architecture and function of the retinal pigment epithelium in the back of 
the eye. 
2.1. The structure of the eye and the retina 
The diameter of the eyeball in humans is approximately 2.5 cm. The outer layer of the 
eyeball is a strong fibroelastic capsule, sclera. However, in front of the eye the sclera 
transforms into a transparent cornea. The cornea is mostly responsible for the refraction 
of the light in the eye, and it roughly focuses the light onto the retina. Inside the sclera, 
there is a loose vascular tissue layer called choroid. Interestingly, the choroid is heavily 
pigmented, which absorbs the light passing through the retina. The choroid merges with 
ciliary body in front of the eye. The iris is also an extension of the choroid and it is also 
heavily pigmented. The color of the eyes changes between individuals according to the 
amount of pigment in the iris. An aperture of the eye is called a pupil. Behind the pupil 
there is a clear and elastic lens, which attaches to the ciliary body with suspensory 
ligaments. The lens enables the accurate refraction of the light into the retina by 
changing its form. Furthermore, the lens divides the eyeball into smaller anterior 
chamber and gel-like vitreous body. The light that enters the eye is focused on the 
retina, which forms the inner lining of the posterior compartment of the eye. The optic 
nerve consists of the afferent nerve fibres from the retina, and it leaves the eye through a 
part of the sclera. (Haug et al. 1999; Young et al. 2006) The structure of the eye is 
presented in the Figure 1.  
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Figure 1. The structure of the eye. (Modified from the source Kolb et al. 2005) 
 
The light is absorbed in retina, which contains three types of cells: neurones, pigmented 
epithelial cells and supporting cells. The retina is approximately 0.5 mm thick and lines 
the back of the eye. All vertebrae retinas are composed of three layers of nerve cell 
bodies and two layers of synapses. The outermost layer of the retina consists of the RPE 
cells, which lay on top of the Bruch’s membrane (BM) and separates the retina from the 
choroid. The rod and cone photoreceptors embed their tips into the microvilli of RPE 
cells forming a photoreceptor layer. The photoreceptor layer includes a thin eosinophilic 
structure known as the outer limiting membrane, which separates the rod and cone 
processes of the photoreceptors from the densely packed nuclei called outer nuclear 
layer. The outer plexiform layer contains synaptic connections between photoreceptor 
cells and integrating neurones, whereas the cell bodies of these neurones, such as 
bipolar, horizontal, and amacrine cells, lie in the inner nuclear layer. Besides these 
integrating neurones, Müller glia cells, which are analogous to the neuroglia in the 
central nervous sytem, embrace the retinal neurones filling all the intervening spaces. 
The integrating neurones make synaptic connections with dendrites of ganglion cells in 
the inner plexiform layer. The axons of retinal ganglion cells form the optic tract. 
Finally, the inner limiting membrane distinguishes the retina from the vitreous body. 
(Young et al. 2006; Kolb et al. 2007) A simplified picture of the structure of the retina is 
illustrated in the Figure 2.  
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Figure 2. A simplified picture of the structure of retina. (Modified from the source Kolb 
et al. 2005) 
2.2. The retinal pigment epithelium 
RPE is a monolayer of darkly pigmented cells which are anatomically situated between 
the neural retina and the choriocapillaris. RPE arises from the neuroectoderm and it is 
considered to be a part of the retina. It plays a crucial role in support and function of 
retina and its photoreceptors, such as formation of the blood-retinal barrier (BRB), 
regeneration of visual pigment, transportation of nutrients, and absorption of stray light. 
Anatomically the RPE is aligned so that the apical membrane of RPE is face to the 
photoreceptors whereas basal surfaces of the cells rest on BM. (Simó et al. 2010) 
2.2.1. Development of RPE in vertebrates 
Organogenesis of the eye is a multiphase process that begins with the formation of optic 
vesicles after which the distal domain of the vesicles folds inward in the development of 
the bilayered optic cup. The formation of the optic vesicles and the optic cup takes place 
in the ventral forebrain during the final stages of neural tube formation. This process is a 
delicate and well-coordinated process between neuroepithelium, surface ectoderm and 
extraocular mesenchyme. The neural retina develops from inner layer of the optic cup 
whereas the RPE is derived from the outer layer. Tissue-tissue interactions, which are 
mediated by extrinsic and intrinsic factors and signals such as transcription factors, play 
a crucial role in the differentiation of ocular tissues starting from the optic vesicle stage. 
(Bharti et al. 2006; Fuhrmann 2010) The formation of the optic cup in early eye 
development is illustrated in Figure 3. 
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Figure 3. Formation of the optic cup and RPE in early eye development. (Modified from 
the source Fuhrmann 2010) 
 
The RPE is specified at the early optic vesicle stage already before the 
pigmentation comes visible. The early markers on gene expression level that show 
domain-specific expression for retina and RPE are the visual system homeobox 2 
(VSX2) and microphthalmia-associated transcription factor (MITF). (Fuhrmann 2010) 
During human RPE development, the first signs of pigmentation are seen in the external 
layer of the optic cup approximately on post-ovulatory weeks 5 to 6. (Vugler et al. 
2007) Transcription factors MITF and orthodenticle homeobox 2 (OTX2) play crucial 
roles in RPE specification; MITF is the first gene that is specifically expressed in the 
developing RPE in the optic vesicle and it is also a key regulator of pigment cell 
development in the RPE, whereas OTX2 activates expression of pigment genes in 
cooperation with MITF. (Bharti et al. 2006; Fuhrmann 2010) Transcription factors and 
functional proteins involved in development of the RPE and photoreceptors are listed in 
Figure 4.  
 
Figure 4. Expressions of transcription factors and functional proteins in development of 
the eye. (Modified from the sources Meyer et al. 2009 & Vaajasaari et al. 2011)  
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The most important extrinsic factors in RPE development are proteins of the 
transforming growth factor β (TGFβ) superfamily, such as bone morphogenetic proteins 
(BMPs); factors of the hedgehog (HH) family; and fibroblast growth factors (FGFs). 
For instance, the surface ectoderm expresses BMPs which have shown to induce MITF 
expression and induce RPE fate in the optic vesicle. (Bharti et al. 2006; Müller et al. 
2007) Instead, basic fibroblast growth factor (bFGF) promotes the developing RPE to 
transdifferentiate into neural progenitor cells. In addition, the Wnt signalling pathway 
affects on the undifferentiated retinal progenitor by inducing the formation of the 
laminar structure of the retina. (Vugler et al. 2007) 
2.2.2. The RPE cells 
The RPE cells possess the anatomic features of a typical monolayer epithelium with 
tightly packed cubical or columnar cells and microvilli on the apical side of the cells. 
The apical microvilli surround the light-sensitive outer segments of the photoreceptors. 
(Strauss 2005) The cytoplasm of the cells is compartmentalized along an apico-basal 
axis; a well-developed epithelium has cell organelles and cytoskeletal molecules 
localized to specific sub-cellular positions. (Klimanskaya et al. 2004; Burke et al. 2008) 
Furthermore, the polarized RPE cells have a substantially regular hexagonal 
organization when viewed from above the surface. (Burke 2008) Mature RPE cells do 
not normally divide, but they can start to proliferate in response to injury or 
photocoagulation. In these cases, the RPE cells nearby the damaged area flatten and 
proliferate forming a continuous monolayer. (Klimanskaya et al. 2004) The 
cobblestone-like morphology of RPE cells and RPE monolayer are illustrated in Figure 
5.  
 
 
Figure 5. The cobblestone-like structure and pigmentation of human foetal RPE 
monolayer. Scale bar 100 µm. (Modified from the source Voloboueva et al. 2005) 
 
Several studies have shown that RPE can form fibroblast-like cells that can later 
revert to their original RPE cell morphology. (Lee et al. 2001) One of the most obvious 
markers of mature RPE cells is the formation of brown pigment called melanin inside 
the cells. The pigment is inside small granules, melanosomes. When RPE cells are 
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propagated in the culture, they lose their pigmentation as melanosomes are exocytosed 
or diluted by cell division. However, RPE cells are able to gain the lost pigmentation in 
a process called re-melanization. Nevertheless, biosynthesis of melanin is a slow 
process which requires weeks of confluency of the RPE cells. (Burke et al. 2008; Gamm 
et al. 2008) In between the RPE cells there are tight, adherens and gap junctions, which 
create a barrier between the subretinal space and choriocapillaris. For RPE the 
paracellular resistance is 10 times higher than the transcellular recistance. (Strauss 
2005) 
2.2.3. The functions of RPE 
Sense of sight is a delicate and complicated system in which the RPE has a significant 
and vital role. First and foremost RPE participates in light absorption and protection 
against photo-oxidation. The RPE increases optical quality by forming a heavily dark 
pigmented lining of the inner bulbus, which contributes to absorption of scattered light. 
In the eye, light enters via pupil and is focused onto the macula lutea by the lens. 
Therefore the light energy is concentrated onto the retina. The RPE contains a complex 
composition of several pigments that absorb light in specialized wavelengths, such and 
melanin and lipofuscin. The general light absorption occurs via melanin in 
melanosomes. In addition, this light absorption is supplemented by pigments in the 
photoreceptors, such as lutein and zeaxanthin. These pigments absorb blue light, which 
appears to be most dangerous for the RPE cells. Melanosomes and blue light absorpting 
pigments are only responsible for the absorption of approximately 60 per cent of light 
energy (Strauss 2005; Simó et al. 2010) Besides light absorption, the RPE protects the 
retina by counterbalancing the high oxidative stress. This is mediated by the high 
amounts of antioxidants, such as superoxide dismutase and catalase in RPE. (Miceli et 
al. 1994) 
The RPE has a vital role in the visual cycle. Light transduction is initiated by the 
absorbtion of light by rhodopsin. Rhodopsin is composed of opsin and a chromophore 
11-cis-retinal. When light is absorbed, the conformation of 11-cis-retinal changes into 
all-transretinal. All-transretinal is metabolized into all-transretinol by photoreceptors 
and transported to the RPE. In the RPE, the all-transretinol is reisomerized to 11-cis-
retinal and then delivered back to the photoreceptors. The protein retinal pigment 
epithelium specific protein 65 kDa (RPE65) is responsible for the isomerization of the 
all-trans-retinaldehyde to its photoactive 11-cis-retinaldehyde. In addition, a cellular 
retinaldehyde binding protein (CRALBP) is related to the retinoid metabolism. Both 
proteins are molecular markers for RPE. (Klimanskaya et al. 2004; Burke et al. 2008; 
Simó et al. 2010) The functions of RPE are illustrated in Figure 6.  
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Figure 6. The functions of the RPE. (Strauss 2005) 
 
The RPE transports nutrients and ions between the choriocapillaris and 
photoreceptors. This epithelial transport through RPE is therefore bidirectional. Energy 
for transepithelial transport is provided by Na+- K+-ATPase on the apical membrane of 
RPE cells. Neurons and photoreceptors in retina produce large amounts of water as a 
result of their metabolic turnover. In addition, intraocular pressure moves water from 
the vitreous body into the retina. Thus, there is a constant need for removal of water 
from retina by RPE cells. The transport of water is mainly driven by a transport of Cl- 
and K+. (Hamann 2002) A protein that plays an important role in chloride conductance 
and calcium signalling in the RPE cells is bestrophin. Bestrophin is also a commonly 
used molecular marker for RPE cells. (Klimanskaya et al. 2004; Burke et al. 2008) Due 
to the high paracellular resistance of RPE epithelium, water transport occurs mainly 
transcellularly and it is facilitated by aquaporins. (Hamann et al. 1998) Furthermore, 
metabolic end products from the photoreceptors, such as lactid acid, are eliminated by 
the RPE into the blood circulation. (Strauss 2005) RPE is also responsible for the 
transportation of nutrients, such as glucose, retinol and fatty acids from blood into the 
retina. The import of retinol is extremely important to ensure enough retinol to the 
photoreceptors. The vitamin A uptake from the blood constitutes additional supply to 
the visual and retinoid cycle. (Baehr et al. 2003) 
 Another important function of the RPE is the phagocytosis of shed 
photoreceptor outer segments. Exposure of photoreceptors to intense levels of light 
leads to accumulation of photodamaged proteins and lipids. Thus, to preserve the 
excitability of photoreceptors, their outer segments undergo constant renewal. These 
damaged tips of photoreceptor outer segments are phagocytosed by the RPE in such 
manner that essential molecules, such as retinol, are redelivered to photoreceptors. The 
RPE is also known to produce and secrete growth factors as well as essential factors for 
the maintenance of the retina and choriocapillaris. For instance, the RPE is able to 
secrete pigment epithelium derived factor (PEDF), vascular endothelial growth factor 
(VEGF), FGFs, TGF-β, insulin-like growth factor-I (IGF-I), nerve growth factor (NGF), 
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brain-derived growth factor (BDNF), neurotrophin-3 (NT-3), platelet-derived growth 
factor (PDGF) and chemokins. Among these numerous factors, PEDF and VEGF seem 
to be the most significant ones. For instance, PEDF has a property of inhibiting 
angiogenesis. (Strauss 2005, Simó et al. 2010)  
2.2.4. Bruch’s membrane 
Bruch’s membrane (BM) is an extraordinary pentalaminar membrane composed of 
extracellular matrix proteins between the RPE and the choroid. Due to its unique 
location and structure, BM plays a vital role in cell-cell communication, cellular 
differentiation, proliferation and migration, tissue remodelling as well as in shaping of 
pathological processes. The main components of BM are laminin, collagen type IV, 
fibronectin and collagen I. BM is an acellular layer, and most probably its extracellular 
matrix (ECM) constituent production is dependent on the adjacent RPE and choroidal 
cells.  (Booij et al. 2010) 
The three most important functions of the BM consist of regulating the diffusion 
of molecules between the choroid and the RPE, providing physical support for the 
anchorage dependent RPE cell adhesion, migration and differentiation as well as acting 
as a division barrier restricting choroidal and retinal cellular migration. The BM acts as 
a semi-permeable barrier for reciprocal exchange of biomolecules between retina and 
choroid. This diffusion of molecules is mainly passive due to the acellular nature of 
BM. Several factors affect the diffusion over BM, such as age and location in retina. 
Furthermore, diffusion through the BM depends also on hydrostatic pressure on both 
sides of the BM and concentration of specific biomolecules and inorganic ions. 
Biomolecules such as nutrients, lipids, pigment precursors, vitamins, oxygen, minerals, 
anti-oxidant components and serum constituents are taken up by the RPE via BM from 
the bloodstream. In contrast, CO2, water, ions, oxidized lipids, oxidised cholesterol and 
other waste products from the RPE pass the BM to choroid and bloodstream.  The role 
of BM as substrata for the RPE is vital. The adhesion of RPE cells on BM is mediated 
by integrin cell surface receptors. These integrin receptors are a group of RPE basal 
membrane proteins that are able to bind a number of extracellular components such as 
laminin and type IV collagen. (Booij et al. 2010) 
2.3. Retinal disorders 
As the population is ageing and the average life expectancy is rising over 80 years in the 
developed countries, the amount of people suffering from degenerative diseases is 
increasing. 90% of the visually impaired persons live in the developing countries. 
Degenerative diseases affecting the retina eventually lead to irreversible weakening of 
vision and may cause blindness. Today, there are approximately 180 million visually 
impaired persons in the world out of which 40 to 45 million are completely blind and 
the rest more or less weak-sighted. Regenerative diseases affecting the retina are the 
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leading cause of blindness worldwide in the elderly. (Finnish Federation of the Visually 
Impaired 2011; WHO 2011) 
2.3.1. Age-related macular degeneration 
AMD is the most common cause of blindness among people over 60 years of age. In 
industrialised countries, clinical signs of AMD are detected at least in one third of 
persons over 75 years. In Finland, every tenth person over 60 years of age suffers from 
AMD (Finnish Federation of the Visually Impaired 2011), and the disease is estimated 
to affect over 30 million people worldwide out of which 14 million are blind or severely 
visually impaired. (Gehrs et al. 2006)  
The AMD is an ocular condition where the central area of retina known as 
macula is damaged. The AMD occurs either as a consequence of neovascularization or 
from cell loss due to the geographic atrophy. The first is more commonly referred to as 
wet form of AMD and the latter as dry form. The AMD is generally thought to progress 
from the dry form into the wet one with approximately 10 to 15% of AMD patients 
finally developing the wet form. The AMD does not usually show clinical marks before 
the age of 55. Clinical signs of dry AMD are pigment disruption and formation of 
drusen in between RPE and BM. In addition, geographic atrophy and RPE changes are 
also seen in dry AMD. The clinical signs of wet AMD include fluid, exudates and blood 
in the extracellular space between the neural retina and the RPE. The wet form of AMD 
is a more rapidly progressing form and it may result in a sudden loss of central vision.  
(Gehrs et al. 2006; Nowak 2006) 
 The therapeutic approaches for AMD have focused mainly on the wet form of 
AMD due to its rapid progression and debilitating nature. However, there is neither 
prophylactic therapy nor a cure for the disease. The current treatments aim to avoid 
further vision loss rather than to improve vision. (Gehrs et al. 2006) The most promising 
results have been gained with anti-VEGF therapy with reasonable proportion of patients 
showing vision improvements. However, these anti-VEGF treatments require monthly 
injections and visits to physicians. (Nowak 2006; Miller et al. 2010) 
2.3.2. Retinitis pigmentosa 
Retinitis pigmentosa (RP) is a family of inherited heterogenous retinal diseases which 
are characterized by progressive RPE degeneration and photoreceptor apoptosis. In fact, 
the RP is the most common inherited retinal disorder with approximately 1.5 million 
persons affected worldwide. The clinical presentation of RP may alternate, but in 
general it leads to the progressive degeneration of the photoreceptors causing problems 
such as night blindness and visual field defects. The RP includes several disorders with 
diverse chromosomal, metabolic and morphologic findings, of which many are 
genetically predetermined. (Shintani et al. 2009) Most of the damaged genes that have 
been discovered concern the rod photoreceptors (Kolb 2007). Clinical findings in RP 
include arterial narrowing, hyalinization, and waxy optic disc pallor. Changes in 
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pigmentation of RPE and migration of RPE into retina are also found. RP usually 
affects one eye, but cases where both eyes are damaged have also been reported. 
(Shintani et al. 2009; Natarajan 2011) As for AMD, there is no cure for RP. The 
research of treatment for RP is focused on investigational therapies such as gene therapy 
to correct the specific mutations, cell transplantation to replace the lost cells and 
pharmacologic substances to preserve the photoreceptors. (Shintani et al. 2009) 
2.4. Transplantation of RPE cells 
In many cases of retinal degeneration, the inner layers of the retina and associated 
neural and glial cells and the optic nerve remain their functionality and organized 
structure for a period of time. Therefore, by introducing a population of healthy cells, 
with the capacity to promote photoreceptor survival, into the damaged subretinal area, 
the vision could be restored. (Hynes et al. 2010) Transplantation of healthy RPE cells 
will not only fill in the cells lost during degeneration, but RPE also secrete ECM 
proteins and PEDF, which possess antiangiogenic properties, and VEGF. Most of the 
RPE transplantation studies in humans have focused on the treatment of wet AMD.  (da 
Cruz et al. 2007) 
 Adult and fetal RPE cells have been transplanted into the subretinal space of 
several animal models as well as into humans. Autologous cells, genetically modified 
RPE cell lines, homologous and heterelogous RPE cells as suspensions or as 
monolayers on substrates have been investigated in transplantation purposes. (Algvere 
et al. 1999; Cruz et al. 2007; Sheridan et al. 2009) The feasibility of mature adult RPE 
cells in AMD has been demonstrated by autologous transplantation of RPE cells from 
the periphery of the patients own RPE (Binder et al. 2002). Even though the mature 
adult RPE cells might survive after transplantation to some extent, they often fail to 
exhibit widespread integration with host retina and end up forming irregular rosette-like 
structures instead of monolayers (Hynes et al. 2010).  
 HPSC-derived RPE cells are considered to be a potential cell source for 
transplantation purposes for dry form of AMD. The use of human embryonic stem cell 
(hESC)-derived RPE cells could be used in the treatment of the dry form of AMD, 
where the BRB is intact and the blood cells cannot enter the subretinal space. (Sheridan 
et al. 2009; Hynes et al. 2010) The first clinical trials with hESC-derived RPE cells for 
the treatment of advanced dry form of AMD are ongoing. The phase I and II clinical 
trials are conducted in United States by Advanced Cell Technology (ACT).  Recently, 
ACT got an approval to start clinical trials in United Kingdom and United States with 
hESC-derived RPE cells to treat Stargardt's macular dystrophy, which is the most 
common form of inherited juvenile macular degeneration. (ACT 2011) 
 The delivery of cell suspensions into the subretinal space usually results in poor 
cell survival. Furthermore, the organization of transplanted RPE cell suspensions and 
tissue is abnormal and the monolayer structure of intact RPE with transplanted cell 
material is yet to be gained. RPE transplantations with scaffolds have shown 
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improvements in RPE cell survival and organization. The scaffolds provide the cells 
structural support, aid in cell delivery, direct cell behaviour and can also deliver drugs 
or growth factors.  (Hynes et al. 2010) An ideal scaffold for RPE transplantation should 
be biocompatible and extremely thin, 5 to 90 µm, in order to fit the subretinal space. 
Furthermore, the scaffold material should be implantable by a minimal invasive surgery 
technique. The material must also be mechanically durable and flexible to withstand 
surgical manipulation and avoid harming surrounding tissue. In addition, the material 
must have good permeability or porous structure in order to have sufficient delivery of 
nutrients and other substances. Several scaffold materials for RPE cell transplantation 
has been tested. (Hynes et al. 2010) For instance, collagen, PLLA, PLGA, gelatine, 
poly(glycerolsebacate), poly(methylacrylate/methacrylamide), poly(dimethylsiloxane) 
(PDMS) and polyurethanes have been studied as possible scaffold materials for RPE 
cell transplantation (Giordano et al. 1997; ; Binder et al. 2007; Hynes et al. 2010).  
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3. STEM CELLS 
3.1. Human embryonic stem cells  
The discovery of the cells which are able to divide indefinitely and differentiate into 
specialized cell types has opened new avenues for regenerative medicine (Vazin et al. 
2010). The cells in question are stem cells and they possess an enormous differentiation 
potential towards somatic cell types. Stem cells are undifferentiated cells, which can 
divide in two possible ways: symmetrically or asymmetrically. In symmetric division, a 
stem cell divides into two identical stem cells (Bongso et al. 2004). This process is 
called self-renewal. In asymmetric division, also called differentiation pathway, one 
daughter cell remains as a stem cell and the other differentiates into a precursor cell, 
which proliferates and continues to differentiate towards specialized cell type. The 
difference between a stem cell and a precursor cell is that stem cell has telomerase 
activity, which enables the cell to divide without a limit. Telomerase is an enzyme, 
which adds short DNA sequences, telomeres, to the ends of eukaryotic chromosomes. 
(Raff 2003) 
Stem cells can be classified in two ways, either according to their source or 
development potential. The fertilized egg, zygote, is a source of totipotent stem cells. 
ESCs are derived from the inner cell mass (ICM) of a blastocyst. ESCs are pluripotent 
and they can be expanded in vitro and kept in this pluripotent phenotype indefinitely. 
(Langer et al. 2007) In an adult human body, somatic adult stem cells (ASCs) are found 
in most tissues and organs. Examples of ASCs are mesenchymal stem cells (MSCs), 
which are widely spread in the connective tissues, and neural stem cells (NSCs) found 
in the central nervous system. The limitation with the adult stem cells is that they are 
sparsely distributed in tissues and difficult to isolate. Stem cells from the foetus have 
been used in research, as well. (Bongso et al. 2004) The classification of stem cells 
according to their development potential is also a common way. Totipotent cells have 
the capability to form all the cell types of an individual and are basically capable of 
forming the entire organism. The term pluripotency means that those stem cells lack the 
latter feature, but they are able to produce all the cell types of all three germ layers. The 
cells producing more than one cell type in tissues are said to be multipotent and those 
producing only one are unipotent. (Raff 2003) 
hESCs are isolated from donated spare embryos of blastocyst stage after in vitro 
fertilization (Thomson et al. 1998). ICM consists of a cluster of 10 to 30 cells inside a 
five to eight day old embryo. (Bongso et al. 2004) Furthermore, hESCs can be derived 
from earlier morula-stage human embryos or intact blastocysts, from which the 
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glycoprotein shell zona pellucida has been removed (Trounson 2006). Colonies of 
hESCs differ from ICM in many ways: ICM preserves a memory of axes, where as 
ESCs are capable of indefinite proliferation in vitro. The hESC lines also express high 
levels of telomerase activity. (Thomson et al. 1998) hESCs grow in tightly packed 
colonies which have defined borders at the periphery of the colonies. Individual hESCs 
have a high nucleus to cytoplasm ratio and a prominent nucleoli. In addition, hESCs 
express classical markers of pluripotent cells such as OCT4, nanog, TRA antigens, 
state-specific embryonic antigen-4 (SSEA-4), SSEA-3 and alkaline phosphatase. (Vazin 
et al. 2010) Conventional way of testing the pluripotency of hESCs is teratoma 
formation as a xenograft to immune-compromised mice. A teratoma is an encapsulated 
tumor with cells or tissues representing all the three germ layers of the embryonic disc 
(Ergec et al. 2009). hESCs exhibit many differences from mouse embryonic stem cells 
(mESCs): the growth of hESCs is slower and they tend to form flat colonies instead of 
spherical ones. First hESC lines were derived by Thompson et al. in 1998. (Thomson et 
al. 1998) 
Nowadays several protocols for derivation of hESC-lines have been established 
and also numerous studies of culturing undifferentiated hESCs and their differentiated 
progeny have been performed (Stojkovic et al. 2004). To date, isolation of the ICM 
from blastocysts has been achieved for the most part by immunosurgery or mechanical 
dissection. The first few hESC lines were established using the immunosurgical method. 
However, this procedure requires the use of animal-derived products, such as anti-
human serum antibodies and guinea pig complement, which may prevent the later use of 
these hESCs in transplantation therapies due to the possible transfer of pathogens into 
patients. Therefore, the mechanical or enzymatical dissociation of ICM in such manner 
that avoids the use of animal-derived products during the derivation process would be 
advantageous from the clinical point of view. (Vazin et al. 2010) 
The first hESC lines were cultured on mouse embryonic fibroblast (MEF) feeder 
layers, which support the propagation of hESCs in undifferentiated state. However, in 
order to move towards xeno-free hESC culture systems, several approaches exploiting 
human-derived cell types such as fibroblast feeder cells derived from fallopian tube 
epithelium, fetal foreskin, muscle, bone marrow, or amniotic epithelium. Optionally, 
hESCs can be cultured in feeder-free cultures in the presence of extracellular matrixes 
such as MatrigelTM and fibronectin. Medium conditioned by feeder fibroblast cells and 
supplemented with bFGF has been initially used to maintain hESCs in undifferentiated 
state in feeder-free environment. (Vazin et al. 2010) 
Despite the fact that hESCs maintain their pluripotent nature, it is evident that 
hESCs can acquire karyotypic abnormalities during prolonged maintenance in vitro. 
These chromosomal deviations are thought to be a result of in vitro adaptation and 
selection since abnormal rapidly-dividing cells step by step predominate and take over 
the entire culture. (Baker et al. 2007) Therefore, the hESC cultures intended for 
therapeutic use are regularly karyotyped with traditional Giemsa-staining, which detects 
large chromosomal changes, or with other methods such as fluorescent in situ staining, 
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DNA microarray, whole-genome single nucleotide polymorphism, and short tandem 
repeat analysis. (Vazin et al. 2010) 
3.2. Induced pluripotent stem cells  
The use of hESCs in therapeutic purposes in regenerative medicine arouses ethical 
concerns. Moreover, the possible tissue rejection following transplantation of hESCs 
into patients constricts the use of hESC as a therapeutic tool. Several strategies to 
induce pluripotency in already mature somatic cells has been conducted, such as 
somatic cell nuclear transfer and fusion of somatic cells with ESCs, in hopes of 
generating patient-specific cells of any lineage. However, these protocols confronted 
technical, ethical and logistical barriers that restricted the use of resulting pluripotent 
cells in both research and clinical therapy. (Maherali et al. 2008) The idea of using 
patient’s own cells and generating them into induced pluripotent stem cells (iPSCs) took 
a huge step forward in 2006 by Takahashi and Yamanaka, who reprogrammed mouse 
embryonic and adult fibroblast cultures to pluripotent stem cells by retroviral delivery of 
four transcription factor genes; sex-determining region Y- box 2 (SOX2), octamer 4 
(OCT4), Krueppel-like factor 4 (KLF4) and C-MYC.  The research of Takahashi et al. 
was groundbreaking for the field of regenerative medicine; already mature somatic cells 
were reprogrammed back to pluripotent cells with a large capacity to differentiate into 
mature cell types without the use of embryonic material. (Takahashi et al. 2006) The 
first hiPSC lines were derivated a year later by Yu et al. and Takahashi et al. from 
human fibroblasts. Takahashi et al. reprogrammed the cells with same four transcription 
factors as reported in their pioneer work with iPSCs, whereas Yu et al. showed that 
reprogramming of human induced pluripotent stem cells (hiPSCs) can be induced by 
SOX2, OCT4, NANOG and LIN28. (Yu et al. 2007; Takahashi et al. 2007) 
 Properly reprogrammed iPSCs possess wide range of properties including loss 
of somatic cell-specific markers, expression of appropriate stage-specific embryonic 
antigens, telomerase activity, X chromosome reactivation in female cells, reactivation of 
endogenous genes for pluripotency and self-renewal such as SOX2, OCT4 and NANOG, 
and silencing of exogenous factors for the initiation of reprogramming. Moreover, 
iPSCs are able to self-renew and contribute to all three germ layers during teratoma 
formation similar to ESCs. (Cox et al. 2010) Morphologically, the iPSCs appear 
identical to ESCs. Also, human iPSCs as well as ESCs survive poorly as single cells. 
Therefore, the initial passaging of new colonies must be done mechanically and several 
passages are required before the cells can be adapted to enzymatic dissociation. 
(Maherali et al. 2008)  In addition, hiPSCs seem to require an FGF, such as FGF2, to 
maintain their pluripotency and self-renewal capacity in culture conditions.  
Interestingly, gene expression profiling has revealed slight differences between hESC 
lines and iPSC lines. (Cox et al. 2010) Furthermore, the general assumption that 
autologous iPSCs are not immunogenic might need more inspection. The study of Zhao 
et al. in mice suggests that abnormal gene expression in some cells differentiated from 
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iPSCs can induce T-cell-dependent immune response in genetically identical recipients. 
Therefore, the immunogenicity of therapeutic cells derived from patient-specific hiPSCs 
should be examined before transplanting these cells into patients. (Zhao et al. 2011)  
Figure 7 illustrates the reprogramming of somatic cells into pluripotent stem cells.  
 
Figure 7. Reprogramming mature somatic cells to iPSCs. (Cox et al. 2010) 
 
Since the first reprogramming by Takahashi and Yamanaka, it has become clear that 
there is some flexibility in the factors required for reprogramming somatic cells. For 
example, c-Myc is not strictly needed for the reprogramming of somatic cells. However, 
when c-Myc is left out from the reprogramming factors, the time required for the 
protocol is significantly longer, and the efficiency of the protocol decreases 
dramatically. Human fibroblasts have also been reprogrammed using a gene 
combination of SOX2, OCT4, LIN28 and NANOG. Alternatively, some reprogramming 
factors can be replaced by transcription factors from the same family. In general, the 
specific factors required for reprogramming depend on the somatic cell type being 
reprogrammed. (Cox et al. 2010) 
 A variety of methods exist for iPSC derivation (Maherali et al. 2008). Several 
reprogramming protocols are based on retroviruses or lentiviruses, which integrate into 
the genome of somatic cells and express the exogenous reprogramming factors. 
However, the continuous expression of reprogramming factors and the possibility for 
insertional mutagenesis are justified concerns and risks which complicate the clinical 
use of hiPSCs. (Cox et al. 2010) Therefore, reprogramming protocols in which the 
genetic material would not permanently integrate into the genome have been developed. 
One approach has been a protocol in which the genetic material is first integrated into 
the genome and later removed. In these protocols, after the viral integration and 
reprogramming, recombinases were used for removing the reprogramming factors from 
the genome. (Soldner et al. 2009; Kaji et al. 2009) In addition, non-nucleic acid based 
rerprogramming protocols have been investigated. For example, purified recombinant 
proteins of transcription factor genes containing a polyarginine protein transduction 
domain in their C-termini resulted in iPSC formation after 30 days after the initiation of 
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reprogramming. (Zhou et al. 2009) Furthermore, the use of small molecules, such as 
valproic acid and 5-aza-cytidine, has been shown to result in fully reprogrammed iPSCs 
(Huangfu et al. 2008; Mikkelsen et al. 2008). 
3.3. Culturing hPSCs in feeder-free conditions 
Culturing undifferentiated hPSCs for a long period of time in vitro is traditionally 
carried out on fibroblast feeder cell layers. However, using feeder cells in hPSC cultures 
is quite vulnerable and limits the production of hPSCs in larger amounts for the possible 
use in regenerative medicine. The production of feeder cells is laborious. In addition, 
the goal towards xeno-free hPSC cultures and clinical applications restricts the use of 
animal-derived materials, such as fetal bovine serum (FBS), commonly used in 
fibroblast feeder cell propagation. In addition, the function of feeder cells in hPSC 
cultures is not yet fully unravelled. To date, it is evident that feeder cells provide hPSCs 
essential cell-cell contacts as well as vital soluble factors for maintaining the hPSCs in 
undifferentiated state. (Hakala et al. 2009) Feeder-free cultures would be free of many 
challenges related to feeder cell layers.  
 The first cultures of hESCs in feeder-free conditions were created by replacing 
the feeder cells with MatrigelTM. MatrigelTM is an ECM product secreted by mouse 
Engelbreth Holm-Swarm sarcoma cells, which contains mainly laminin, collagen IV, 
heparin sulphate proteoglycan, growth factors and other substances. For example, 
hESCs have been cultured on MatrigelTM in MEF-conditioned media. In these 
conditions, hESCs grew as dense and undifferentiated colonies, but they were 
surrounded by differentiated cells in between the colonies. (Xu et al. 2001) In addition, 
MatrigelTM has been used as a culture substrate for hESCs by several other research 
groups with supplements such as conditioned media (CM) and serum replacements (SR) 
(Xu et al. 2004; Sato et al. 2004; Xu et al. 2005; Wang et al. 2005). Besides MatrigelTM, 
other ECMs have been used for maintaining hESCs in undifferentiated state in feeder-
free conditions. For instance, laminin, fibronectin and combination of collagen IV, 
fibronectin, laminin and vitronectin have been investigated with in combination of non-
defined and defined culture mediums (Xu et al. 2001; Xu et al. 2004; Noaksson et al. 
2005; Ludwig et al. 2006a; Hakala et al. 2009). However, all the research groups who 
have conducted comparative studies with ECMs agree that animal-derived MatrigelTM is 
a superior matrix for maintaining hESCs in feeder-free conditions (Xu et al. 2001; Xu et 
al. 2004; Hakala et al. 2009). 
 For mouse embryonic stem cells (mESCs), the feeder cell layer can be replaced 
by the addition of leukaemia inhibitory factor (LIF) to the culture medium. However, 
this approach is not effective for hESCs. (Thompson et al. 1998) For hESCs, bFGF is 
the most commonly used medium component required for hESC maintenance with or 
without feeder cells. (Xu et al. 2001) Significant concentrations of bFGF can support 
long-term feeder-independent culture of hESCs when supplemented with noggin (Xu et 
al. 2005). Furthermore, supplements such as TGFβ, activin A., keratinocyte growth 
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factor, nicotinamide and sphingosine-1-phosphate/platelet-derived growth factor 
(PDGF) have been shown to improve the survival of hESC cultures (Chase et al. 2007). 
Recently, many publications have described defined xeno-or feeder-free media 
formulations for the maintenance of hESCs (Vallier et al. 2005; Lu et al. 2006; Ludwig 
et al. 2006a; Ludwig et al. 2006b; Wang et al. 2007). Ludwig et al. developed a serum 
and animal protein free medium called TeSRTM that supports derivation and long-term 
culture of hPSCs in feeder-free conditions. However, hESC lines derived with TeSRTM 
were found to be karyotypically abnormal. (Ludwig et al. 2006a) Therefore, Ludwig 
and his colleagues modified the TeSRTM medium into a more economical version, 
called mTeSR®1, which includes some animal-sourced proteins, such as bovine albumin 
source. mTeSR®1  possess the advantage of being fully-defined and serum-free, and it 
can be used in combination with MatrigelTM. (Ludwig et al. 2006b) 
In feeder-free conditions, hESCs often give rise to fibroblast or stromal-like cells 
that may support the maintenance of undifferentiated growth of hESCs. In fact, few 
research groups have indicated that these feeder cells derived from hESCs can support 
their own growth. (Stojkovic et al. 2005; Wang et al. 2005)  However, these cells are 
not immortal and they will senescence after several passages, which limit their 
continuous use. Furthermore, the derivation process of these feeder cells from hESCs 
can be difficult and may result in variable culture conditions. (Vazin et al. 2010) 
Future efforts are necessary in order to develop a totally xeno-free and defined 
culture method for stem cells which maintains the self-renewal capacity and 
proliferation of hPSCs. The current attempts usually involve some animal-based 
substances or result in chromosomal abnormalities and instability therefore limiting the 
therapeutic use of hESCs. In addition, lower cost alternatives are necessary to make use 
of the developed system for routine research. (Chase et al. 2007)  
3.4. Differentiation of hPSCs into RPE cells 
The enormous need for cells that could be used in cell transplantation therapy has driven 
the researchers to find appropriate cell sources for RPE. Particularly hESCs are 
considered to be a potential cell source for RPE transplantation due to the anatomical 
location of RPE in the BRB.  This localization of RPE layer in the inner surface of the 
BRB in the subretinal space separates the transplanted cells from blood circulation and 
therefore is out of reach for the immuno system and immune rejections in dry form of 
AMD. 
Several approaches have been studied in order to differentiate hPSCs into RPE 
cells. The first cells with RPE appearance were identified from primate cultures in the 
beginning of last decade. Kawasaki et al. used a protocol based on stromal cell-derived 
inducing activity (SDIA) from mesenchymal bone marrow cells (PA6 cells) to derive 
pigmented Pax6 positive cells. The first pigmented cells were detected after 3 weeks of 
co-culture with PA6 cells. Also Ooto et al. applied SDIA in RPE induction from mouse 
and primate ESCs. (Kawasaki et al. 2002; Ooto et al. 2003) Later, Aoki et al. showed 
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that Wnt2b signalling increases the production of RPEs from mESCs with SDIA, 
whereas Ueno et al. modified the SDIA protocol by discarding the PA6 cells and 
replacing them by matrix layers of human amniotic membrane. (Aoki et al. 2006; Ueno 
et al. 2006) However, in all of these studies which applied SDIA protocol lentoid bodies 
were seen. 
Klimanskaya et al. derived RPE from hESCs by overgrowing them on MEF 
feeders. The hESCs colonies were allowed to overgrow on MEFs until the colonies had 
lost their tight borders and became multilayered, after which bFGF was removed from 
the culture media. With this approach pigmentation appeared 2 to 6 weeks after starting 
the differentiation. However, only small part of the hESCs differentiated into RPE 
during the period of 3 to 8 weeks. Pigmented areas were selected by hand picking and 
plated on gelatin-coated culture dishes. After transferring pigmented RPEs on gelatin, 
they lost their pigmentation and morphology, and migrated along the culture dish. 
However, when the dish became confluent, the pigment and morphology were regained. 
(Klimanskaya et al. 2004) The overgrowth protocol of hESCs on MEFs developed by 
Klimanskaya et al. was reproduced by Lund and his colleagues with similar findings 
(Lund et al. 2006). The protocol based on overgrowth of hESCs has also been studied 
by Vugler et al. However, in their protocol, they plated the pigmented cells on 
MatrigelTM instead of gelatin. (Vugler et al. 2008) 
Embryoid body (EB) formation without the overgrowth step on feeders has also 
been studied for RPE differention. EBs are 3-dimensional (3D) cell aggregates, which 
give rise to all the three layers of the embryonic disc. Klimanskaya et al. trypsinized 
hESC colonies and transferred them into EB medium described above and into a low 
adherence culture plate. Less than 1% of EB-like cell clusters developed pigment in 
time course of 4 to 8 weeks. However, over the course of 6 to 9 months the cells on the 
surface of EB-like clusters became pigmented. (Klimanskaya et al. 2004) RPE 
differentiation via EB-like protocols has also been studied by others. In these 
experiments, the EB-like clusters were cultured in suspension from 1-3 weeks up to 9 
months. After culturing the EBs in suspension for a while, they were seeded on adherent 
culture dishes with coating, such as laminin. (Meyer et al. 2009; Idelson et al. 2009; 
Nistor et al. 2010)  
Most of these introduced RPE differentiation protocols involved the use of 
undefined and animal-derived components such as bovine serum albumin (BSA) or 
MEFs. The first step towards a defined xeno-free differentiation protocol of RPE was 
taken by Idelson et al. who cultured hESCs on human foreskin fibroblasts (hFFs) 
instead of MEFs in KO-SR medium. (Idelson et al. 2009) Vaajasaari et al. took this 
approach further by successfully differentiating hPSCs into RPE using xeno-free and 
defined culture medium RegES as a base (Vaajasaari et al. 2011). 
Numerous factors have been studied for the induction of RPE differentiation. 
These include Wnt antagonists, nicotinamide, neural induction medium with N2 
supplement and heparin or B27, activin A and TGF-β1. (Meyer et al. 2009; Idelson et 
al. 2009; Lu et al. 2009) Despite several attempts to develop a directed differentiation 
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protocol for RPE from hESCs, efficient protocols have not yet been established. The 
differentiation is not well defined and only small yields of RPE cells are achievable. 
Therefore, the ideal factors to induce direct differentiation are still being vigorously 
investigated. (Rowland et al. 2011) 
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4. MICROPARTICLES 
Microparticles have diameters ranging from 1 to 500 µm (Figure 8). Microparticles 
were used in cell culture studies for the first time in 1967 by van Wezel, who noticed 
that microparticles facilitated the growth of mammalian cells. (van Wezel 1967)  Since 
then, the microparticles have been successfully used in the growth of anchorage-
dependent cells for the production of vaccines and pharmaceuticals, and to expand cell 
populations. Microparticles offer the advantage of providing a larger surface area for the 
growth of anchorage-dependent cells in a suspension cultures, and overcome several 
issues with static cultures, such as the need for large quantities of culture media, space 
expense, inefficient gas-liquid oxygen transfer, presence of concentration gradients and 
difficulties in monitoring and control. (Martin et al. 2011; Sun et al. 2011) In the next 
chapters, the preparation methods and modifications of microparticles and their use and 
potential in cell culture and tissue engineering are introduced. 
 
 
Figure 8. Chitosan microparticles. Scale bar 200μm. (Modified from the source Liu et 
al. 2011)  
4.1. Preparation of microparticles 
The preparation method for microparticles determines the characteristics of the prepared 
particles, including their size. Therefore, knowledge of the experimental parameters 
such as solvents, temperature, stabilizers and stirring rate in preparation protocols are 
vital. Even more crucial is to know how these parameters cause changes in the 
characteristics of resulting particles. For instance, methods based on emulsions, 
nanoprecipitation, salting-out and spray-drying have been used in microparticle 
preparation. (Lassalle et al. 2007)  
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4.1.1. Emulsion-based methods 
In emulsion-based methods the solvent, where the polymer is dissolved in, is 
eliminated. The elimination of the solvent can be conducted either by evaporation or by 
extraction. The emulsion can contain aqueous and oily phases. Usually, the polymer is 
incorporated in to the organic phase, and the emulsifier is contained in the aqueous 
phase. By mixing the two phases, an emulsion is formed. As the solvent evaporates, the 
microparticles are formed. (Lassalle et al. 2007) 
In a simple emulsion, a stabilizing agent is in the aqueous phase. Double 
emulsions are modifications from single emulsions in which the delivered active 
emulsifier is dissolved in an aqueous phase and the polymer is dissolved in an organic 
phase. These solutions are combined and a single emulsion is formed. The formed 
emulsion is then poured into the aqueous media that includes the stabilizing agent after 
which the solvent is removed, and microparticles are solidified. The solvents used for 
polylactide (PLA) and polylactide-co-glycolide (PLGA) need to be immiscible with the 
emulsion solvent. The most commonly used solvents are ethyl acetate and 
dichloromethane (DCM). On the other hand, the function of the emulsifier is to form a 
thin layer around the oil drops and polymer reducing the coagulation of the polymer 
drops and thus stabilize the emulsion. (Lassalle et al. 2007) For instance, Bible et al. 
prepared PLGA microparticles with average particle size between 50-100 µm by a 
single emulsion method. They used polyvinylalcohol (PVA) as a stabilizer and the 
polymer was dissolved in DCM. (Bible et al. 2009)  
4.1.2. Nanoprecipitation 
Nanoprecipitation is based on interfacial deposition of polymers, which is followed by a 
displacement of a semi-polar solvent miscible with water from a lipophilic solution. It is 
a rather easy and reproducible technique that has been used in the preparation of nano-
and microparticles. Nanoprecipitation does not require large amounts of toxic solvents. 
Nevertheless, the main problem with the nanoprecipitation method is the frequent 
agglomeration of the particles due to the absence of a stabilizer. Furthermore, removal 
of solvent residuals from the prepared nano-and microparticles is rather difficult. 
(Lasselle et al. 2007)  
4.1.3. Salting-out 
An alternative method for the widely applied emulsion procedure is salting-out. This 
method includes the use of a solution in which the polymer is dissolved and a water-
miscible solvent such as acetone or tetrahydrofuran. The solution is emulsified under 
vigorous stirring in an aqueous gel that contains the salting-out agent and a stabilizer, if 
required. Addition of large amount of water to the emulsion leads to the formation of 
spheres, which are purified and recovered by cross-flow filtration. The salting-out 
agents are usually electrolytes, such as magnesium chloride, sodium chloride and 
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magnesium acetate. However, also non-electrolytes, such as sucrose, have been used. 
Salting-out is a suitable method for microparticle preparation when high quantities of 
polymer are applied. Nevertheless, the need for extensive purification of the prepared 
particles limits the use of salting-out method. Furthermore, most of the salts used as 
salting-out agents are incompatible with bioactive compounds. (Quintanar-Guerrero et 
al. 1998; Lassalle et al. 2007) 
4.1.4. Spray-Drying 
Spray-drying method is quite often used in microparticle preparation. In this particle 
preparation method, the polymer is dissolved into an organic solution which is then 
sprayed into a hot-air flow. The solvent instantly evaporates in the hot air, and dry 
microparticles can be collected. In spray-drying procedure, organic solvents can be 
avoided. In contrast to the emulsion-based techniques, the spray-drying is a very rapid 
procedure, which makes it scalable for industrial levels.  However, a major limitation 
with spray-drying is a non-uniform particle size. In addition, there might also be 
significant loss of product during the process due to the adhesion of microparticles to 
the walls of the spray dryer or the aggregation of the particles. (Lassalle et al. 2007) 
 As a consequence of these limititations with conventional spray-drying method, 
novel approaches based on the spray system have been developed. For instance, in 
ultrasonic atomization the atomized polymer dispersion was sprayed into a non-solvent 
where the polymer solvent was extracted. As a result, microparticles were formed. 
(Felder et al. 2003) Liu et al. prepared chitosan microparticles with uniform size and 
morphology by a novel microfluidic jet spray drier. They also reported that the particle 
size could be altered by changing the concentration of chitosan solution. (Liu et al. 
2011) Alhnan and his colleagues produced pH-responsive microparticles by spray-
drying aqueous polymer solutions and Yeo and coworkers developed a spray-drying 
system where the production of microparticles occurs on the surface of an aqueous 
droplets generated by a dual microdispenser system. In the latter one, the microparticles 
are formed through the collision of two droplets of the aqueous and the polymer 
solution. (Yeo et al. 2004; Alhnan et al. 2011) 
4.2. Commercial microparticles 
Microcarriers are composed of a stabile matrix that can withstand mechanical forces for 
example in a perfused bioreactor. Today, a vast number of microparticles are in use and 
also commercially available. For instance, microparticles composed of glass, 
polystyrene, collagen, gelatine and dextran with different coatings are available for 
research purposes. Furthermore, microparticles with different coatings and treated 
surfaces are available in order to improve the attachment of anchorage-dependent cells. 
Also, a large number of particles with different size distributions are on the markets. 
(Martin et al. 2011; Sun et al. 2011) Examples of commercial microparticles that are 
available for research purposes are listed in Table 1.  
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Table 1. Examples of commercial microcarriers and their special features available for 
research purposes. (Nedovic et al. 2004; Oh et al. 2009; Chen et al. 201; Martin et al. 
2011; Sun et al. 2011) 
Microparticle Manufacturer Material Special feature Charged group  
Biocarrier Bio-Rad Polyacrylamide Positive charge  Dimethyl-aminopropyl 
BiosilonTM Nunc Polystyrene Negative charge  - 
CellagenTM MP Biomedicals Collagen  -  - 
CultispherTM-G Percell Biolytica Gelatin Macroporous  - 
CultispherTM-S Percell Biolytica Gelatin Macroporous  - 
CytodexTM 1 GE Healthcare Dextran Positive charge Diethylaminoethyl 
CytodexTM 3 GE Healthcare Dextran Gelatin coating  
DEAE Sigma Cellulose Positive charge Diethylaminoethyl 
DE 53 Whatman Cellulose Positive charge Diethylaminoethyl 
HillexTM Solohill Dextran Positive charge Cationic trimethyl ammonium 
HyQSphereTM Solohill Polystyrene  -  - 
QA52 Whatman Cellulose Positive charge Quaternary ammonium 
SphereCol®  Advanced Bio matrix Collagen  -  - 
Tosoh 65PR Tosoh Bioscience Hydroxylated methacrylate  - Primary amine 
 
4.3. Biodegradable microparticles 
Despite there is a vast supply of commercial microparticles available, most of these are 
not that useful in tissue engineering or direct transplantation because they do not 
decompose in the human body. Majority of the commercial biodegradable 
microparticles are composed of gelatin or collagen, which are usually derived from 
different species. Therefore they are animal-derived and might contain potential 
pathogens. Furthermore, trypsin, collagenase and dispase have been used to retrieve 
viable cells from biostabile microparticles for use in cell-based transplantation studies 
with rather poor success. The cells separated from the beads imperfectly after enzymatic 
treatment. Therefore development of the biodegradable microparticles that allow the 
cells to detach when the particles degrade could be an ideal solution. (Sun et al. 2011) 
Biodegradable polymers are capable of degrading into biocompatible byproducts via 
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chemical or enzyme-catalyzed hydrolysis. The biodegradation of specific biomaterials 
makes it possible to implant them into the body without the need of removal of the 
implant by surgical operation. Biodegradable microparticles are very useful because 
they can be administered to a variety of locations in vivo by a syringe needle. (Park et 
al. 2004) In the following chapters, several potential biodegradable polymers for 
microparticle preparation and applications are introduced. 
4.3.1. Biodegradable polymers for microparticles 
Biodegradable polymers such as polyesters, polyanhydrides, poly(orthoesters), 
polyphosphazenes and polysaccharides have been used in preparation of microparticles. 
Especially aliphatic polyesters have attracted interest as potential microparticle 
materials due to their biocompatibility and biodegradability. (Park et al. 2004) 
Polyesters are synthetic polymers which degrade via hydrolytic degradation of 
the ester bonds in their backbone. PLGA is probably the most widely used aliphatic 
polyester in microparticle preparation. The huge popularity of PLGA among researchers 
is based on its adjustable degradation rate and mechanical properties, which can be 
controlled by varying the lactic acid/glycolic acid ratio and by changing the molecular 
weight of the polymers. PLGA polymers are less stiff than the original polyglycolide 
(PGA) polymers. The PLGA microparticles undergo bulk degradation, in which the 
polymer matrix preserves its original shape and mass until significant degradation has 
occurred. As the molecular weight of PLGA decreases, the degradation rate increases. 
(Park et al. 2004; Nair et al. 2007) The properties of PLGA vary naturally according to 
the lactide and glycolide ratios. Amorphous polymers are obtained with a 
lactide/glycolide monomer ratio of 25:75 whereas a copolymer with a monomer ratio of 
80:20 is semicrystalline. When the L-lactide/glycolide-ratio of the copolymer increases, 
the degradation rate of the copolymer decreases due to the more crystalline structure of 
the polymer. By changing the lactic acid to glycolic acid monomer ratios, the 
degradation time can vary from 1-2 to 5-6 months. Furthermore, the lactid acid is a 
chiral molecule, and exists in two optically active forms; L-lactide and D-lactide, of 
which the L-lactide is the naturally occurring form. These optic isomers have an effect 
on the properties of PLGA copolymers, such as crystallinity, as well. (Park et al. 2004; 
Nair et al. 2007; Vroman et al. 2009)  
Other poly(α-esters), PLAs, have proven to be useful in biomedical applications 
due their biodegrability and non-toxicity (Lasselle et al. 2007). The copolymerization of 
L-lactide with D-lactide produces copolymers with different degree of crystallinization 
depending on the monomer ratio used. For example, poly(L-lactide) (PLLA) is a 
semicrystalline polymer with rather low glass transition temperature and quite slow 
degradation rate, whereas poly(DL-lactide) is an amorphous polymer. (Vroman et al. 
2009) With high molecular weight PLLA, the total degradation can take 2 to 5.6 years 
in vivo. The degradation mechanism of PLLA is bulk erosion. Compared to PLGA, 
PLLA has an extra methyl group in its molecular structure. This methyl group increases 
the hydrophobicity of PLLA. Due to a more hydrophobic nature, PLLA has 
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significantly slower degradation time compared to PLGA. In addition, PLLA is more 
resistant to hydrolysis due to the steric shielding effect of the methyl side groups. PLLA 
has also good mechanical properties with good tensile strength, low extension and a 
high modulus. Thus, PLLA is considered to be an ideal biomaterial for load bearing 
applications. (Nair et al. 2007) Chemical structures of common polyesters used in 
microparticle preparation are illustrated in Figure 9. 
 
 
Figure 9. Chemical structures of biodegradable polyesters used in microparticle 
preparation. (Modified from the source Nair et al. 2007) 
 
Besides PLGA and PLA, poly(ε-caprolactone) (PCL) microparticles have been 
prepared. PCL is biodegradable, semicrystalline polymer with low glass transition 
temperature. It is quite hydrophobic polymer, which in combination to crystalline 
structure leads to quite slow degradation rate of 2 to 3 years. Therefore PCL is suitable 
for long-term applications. The PCL devices also undergo hydrolytic degradation. (Nair 
et al. 2007; Park et al. 2004) 
 Eventhough several synthetic biodegradable polymers have been developed for 
biomedical applications, the use of natural biodegradable polymers remains attractive 
because their abundance in nature, good biocompatibility, and processability. Proteins, 
such as collagen, gelatin and albumin, have been studied and used in microparticle 
preparation in addition to polysaccharides, such as starch, dextran, hyaluronic acid and 
chitosan. However, protein-based natural polymers have poor mechanical properties, 
low elasticity, possible immunogenic parts and high cost. Instead, microparticles 
composed of polysaccharides are commercially available at low costs and broad range 
of physicochemical properties. For example, chitosan shows excellent biocompatibility, 
biodegradability and low immunogenicity. Chitosan contains primary amino groups in 
the main backbone that makes the surface of prepared microparticle positively charged. 
(Park et al. 2004; Nair et al. 2007) 
4.3.2. Pharmacologically active microparticles 
Biodegradable polymers allow incorporation of drugs, which can be released in a 
controlled manner. The release rates of the drugs from biodegradable polymers can be 
controlled by biodegradation kinetics of the polymers, physicochemical properties of 
the polymers and the shape of the devices. A variety of drugs can be loaded into these 
particles. (Park et al. 2004) Pharmacologically active microparticles (PAMs) are 
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particles that are able to convey cells on their surface and release a growth factor or 
other pharmacologically active substance simultaneously. The released agent can 
improve the survival, differentiation or integration of cells into host tissue in 
transplantation. The pharmacological agent can also treat the surrounding tissue, 
therefore acting as a drug delivery device. (Tatard et al. 2007) 
 In order to improve the outcome of foetal dopaminergic cell transplantation for 
the treatment of Parkinson’s disease, Tatard et al. incorporated a glial cell-derived 
neurotrophic factor (GDNF) into PLGA microparticles. The effects of implantating the 
foetal dopaminergic cells on PAMs were investigated in hemiparkinsonian rats. The 
transplantation of the cells on PAMs resulted in improved cell survival compared to the 
cells transplanted as suspension. Furthermore, the cells had more neuritis with GDNF 
releasing PAMs than with unloaded PAMs. (Tatard et al. 2007) PAMs have also been 
studied in in vivo differentiation of cartilage from MSCs. Bouffi et al. incorporated a 
chondrogenic differentiation factor TGF-β3 into PLGA microparticles in single 
emulsion method. Human MSCs attached rapidly onto the fibronectin coated PAMs, 
and strong up-regulation of cartilage-specific cell markers was observed after 3 weeks 
cultivation. Moreover, these TGF-β3 containing microparticles resulted in histologically 
resembling cartilage in mice. (Bouffi et al. 2010) 
4.4. Properties and modifications of microparticles 
Many biomaterials as such do not have ideal surface properties for cellular attachment. 
Therefore, modifications of the particle properties to increase the cell attachment are 
necessary. Mainly four approaches have been used for microparticle modifications to 
increase cell attachment. These include coating particles with ECM proteins, changing 
the overall charge of particle surface, surface treatments to increase the hydrophilicity 
of the particles and finally varying the polymer composition and porosity. The 
microparticle surfaces interact with cells mainly by facing ions and low molecular 
weight organic molecules and proteins. The basic idea behind microparticle 
modifications is to design surfaces that mimic the properties of ECM. (Nedovic et al. 
2004) 
4.4.1. Size and shape  
The size and shape of microparticles have an effect on cell propagation and resulting 
yields in microparticle culture systems. The average size and size distribution of 
microparticles should be narrow to achieve homogenous culture conditions in 
microparticle suspension cultures. The preferable size, which can provide the best cell 
growth, depends on the cell type under investigation. In general, the ideal microparticle 
size is considered to be 100 to 230 µm for microporous particles. This size range is a 
compromise between the maximation of the surface area, stability of the dispersion and 
a surface unit per particle. The first two factors favour smaller particle size, whereas the 
latter requires larger surface area to provide adhesion and proliferation of hundreds of 
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cells. (Nedovic et al. 2004) The microparticles in research use today are mostly 
spherical, but also cylindrical microparticles have shown great results in cell culture 
studies (Oh et al. 2009; Leung et al. 2010; Lecina et al. 2010).  
 The size of microparticles has been shown to be the main factor that affects the 
formation and size of aggregates in microparticle suspension cultures. Larger particles 
with diameters of 100 to 200 µm have resulted in larger aggregates and broader 
aggregate size distribution, whereas particles with diameters of 10 µm have shown to 
attach around cell clumps generating smaller aggregates with soft tissue cores. (Lecina 
et al. 2010) The tight aggregates formed by small microparticles have shown to reduce 
the cell yields. This reduction probably results from the limited access of nutrients and 
growth factors to the cells trapped inside the aggregates. (Chen et al. 2011) 
Furthermore, the microparticle size did not influence on differentiation of hESCs to 
cardiomyocytes (Lecina et al. 2010). The cylindrical shape of commercial DE 53 
microparticles is illustrated in Figure 10. 
 
 
Figure 10. Commercial DE 53 microcarriers. Scale bar 200 µm. 
 
 A sphere provides the most favourable thermodynamically environment with a 
reduced surface area to volume ratio. However, this ideal shape does not maximize the 
surface of the material. Therefore, non-spherical microparticles such as disks made of 
polyester fibres or particles with cylindrical shape are also in use. Some cell types, such 
as human colon carcinoma cell line, show better attachment and growth in these 
anisotropic particles. (Nedovic et al. 2004) A comparison between spherical and 
cylindrical microparticles with both particle types having similar surface properties has 
been conducted. In this study, the hESCs on cylindrical particles grew as compact cell-
microparticle aggregates, whereas the hESCs on cylindrical particles formed less tight 
aggregates. Interestingly, the cells on cylindrical microparticles were spread out in thin 
layers between the microcarriers. However, the shape did not have a dramatic effect on 
resulting yields and differentiation. (Chen et al. 2011; Lecina et al. 2011) Even though 
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the size and shape are important parameters, their effects on cell attachment, 
proliferation and differentiation have not yet been thoroughly investigated. 
4.4.2. Coatings  
Coating of microparticles with ECM proteins is the most common approach to increase 
cell attachment on microparticles. Many natural biomacromolecules have domains in 
their structure, which cells regognize as ligands that can specifically bind with integrins 
on the cell membranes. This specific recognization can result in accelerated cell 
attachment and spreading. (Hong et al. 2005) For instance, collagen, laminin, 
fibronectin, gelatin and MatrigelTM have been used for coating biostabile and 
biodegradable microparticles. Examples of coating experiments of microparticles with 
ECM proteins to increase cell attachment on microparticles are listed in Table 2. 
 
Table 2. Coating microparticles with ECM proteins. 
Material Coatings Investigated cell type Source 
Cellulose DE 53 Laminin, MatrigelTM hESCs Oh et al. 2009; Chen et al. 2011 
Cellulose DE 53 Fibronectin,Vitronectin hESCs Chen et al. 2011 
Cytodex TM 1 Laminin hESCs Lecina et al. 2010 
CytodexTM 3 MatrigelTM hESCs Nie et al. 2009; Fernandes et al. 2009; Chen et al. 2011 
HycloneTM MatrigelTM hESCs Lock et al. 2009 
PLA Collagen Chondrocytes Hong et al. 2005; Hong et al. 2008 
PLA Chitosan Chondrocytes Lao et al. 2008 
PLGA Fibronectin Neural stem cells Bible et al. 2009 
PLGA Fibronectin MSCs Bouffi et al. 2010 
PLGA Gelatin ESCs Carpenedo et al. 2010 
PLGA Laminin P19 embyonic carcinoma cells Newman et al. 2004 
PLLA:PLGA blends Laminin ARPE-19 Thomson et al. 2010 
Polyhydroxyethyl-
methacrylate(PHEMA) Laminin, Fibronectin Hepatocytes Denizli et al. 1995 
TOSOHTM 65 Matrigel
TM, Laminin, 
Fibronectin,Vitronectin hESCs Chen et al. 2011 
 
 Several studies have reported improved cell survival in microparticle culture 
systems with ECM-coated microparticles. For example, Thomson et al. compared the 
attachment of ARPE-19 cells on uncoated and laminin-coated blended PLLA and 
PLGA microparticles. Interestingly, no significant difference in cell attachment between 
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laminin-coated and uncoated microparticles was detected by light microscopy. 
However, when cell viability was investigated with lactate dehydrogenase assay, a trend 
towards improved cell viability on laminin-coated particles was seen. (Thomson et al. 
2010) In another study, Bible et al. reported improved attachment and more even 
distribution of neural stem cells on fibronectin-coated PLGA microparticles compared 
to uncoated particles (Bible et al. 2009). Chen et al. investigated several ECM proteins 
for improving attachment and viability of hESCs on multiple commercial 
microparticles. hESC growth was improved on microparticles coated with ECM 
proteins, and laminin and MatrigelTM proved to be essential for stable long-term 
propagation of hESCs on variety of microparticles. (Chen et al. 2011) 
4.4.3.  Charge and hydrophilicity  
History of microparticles started with positively charged microparticles, but later it 
became evident that negatively charged materials as well as amphoteric materials such 
as proteins can also be used (Nedovic et al. 2004). The first microparticles used for cell 
culture purposes were hydrophilic ion-exchange chromatographic beads based on cross-
linked dextran (van Wezel 1967). Biodegradable polymers, such as PLGA and PLAs, 
have been known to be materials of which surfaces are quite hydrophobic and have 
almost no reactive groups in their molecules (Takami et al. 2011). Therefore, efforts to 
increase the hydrophilicity and overall charge of microparticles are required.  
 Addition of charged groups such as DE, polyethylene glycol (PEG) and poly(L-
lysine) have been shown to increase cell attachment and proliferation on microparticles. 
For instance, the effect of PLGA surface charge on chondrocyte attachment on 
microparticles has been investigated. Three different kinds of PLGA microparticles 
having hydrophobic, negatively charged surface and positively charged surfaces were 
compared with each other. The negative surface charge was achieved by preparing the 
particles from uncapped PLGA polymer whereas blending PLGA with PLGA-g-poly(L-
lysine) graft polymer resulted in positively charged particle surfaces. The positively 
charged PLGA microparticles showed the highest cell attachment and proliferation 
compared to the hydrophobic and negatively charged particles. (Chun et al. 2004) PLA 
and PLGA microparticles have been modified with PEG as well. Introduction of PEG to 
the particle surface increased the Zeta potential of the particles. (Takami et al. 2011) 
 One approach to functionalize the surface of biomaterial with reactive groups is 
by means of plasma processing. Plasma is a complex mixture composed of free radicals, 
ions, electrons, atoms, and molecules sustained by an external energy source. (Chu et al. 
2002) Plasma polymerization modifies the surface chemistry of the microparticles, 
increases hydrophilicity and provides sites for the covalent attachment of functional 
groups (Bible et al. 2009). For example, cell attachment on polystyrene microparticles 
can be significantly increased with alkylamine plasma treatment (Piskin 1992). 
Allylamine plasma polymerization of PLGA microparticles have resulted in improved 
coating efficacy and cell attachment of neural stem cells (Bible et al. 2009).  
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 Alternative method to induce the hydrophilicity and change the charge of the 
particle surface is aminolysis. Surface aminolysis is performed to introduce reactive 
NH2 groups, which are transferred into aldehyde groups by reaction with 
glutaraldehyde. These aldehyde groups can react with aminogroups of other molecules, 
such as collagen. Immobilization of collagen on PLA microparticles with surface 
aminolysis resulted in chondrocyte attachment and proliferation on particles. In 
addition, larger amounts of collagen were immobilized on microparticles with higher 
NH2 content. (Hong et al. 2005) 
 Treating PLLA microparticles in aqueous solutions of sodium hydroxide 
(NaOH) have reported to results in formation of carboxyl groups to particle surface. 
These carboxyl groups increase the hydrophilicity of the particle surface, and allow the 
immobilization of peptides. PLLA microparticle surfaces have been immobilized with 
RGD peptide motif with NaOH-treatment. RGD modified particles enhanced adhesion 
and proliferation of chondrocytes in PLA microparticle cultures. (Chen et al. 2006) 
4.4.4. Porosity and blend ratio  
Solid, microporous and macroporous microparticles have been used in suspension 
cultures. Porous microparticles fabricated from biodegradable polymers show great 
potential as substrata for cell cultivation in tissue engineering (Shi et al. 2009). 
Macroporous microparticles have pores in the range between 10 to 400 μm, allowing 
the cells to grow inside the pores. Microporous particles have so small pore size that the 
cells cannot penetrate inside the particles forcing the cells to grow as a monolayer on 
the particle surface. (Castilho et al. 2008)  
 Porous PLA microparticles have been prepared with double emulsion solvent 
evaporation method. Good cell attachment and spread on these porous PLA particles 
was seen with human osteosarcoma cells. (Shi et al. 2009) In another study, porous 
PLGA microparticles resulted in improved preadipocyte cell survival compared to 
nonporous particles. (Chung et al. 2009) hESCs have been cultured on macroporous 
commercial Cytopore 2 and CultispherTM G microparticles as well. However, low cell 
yields were reported. The macroporous microparticles might provide a non-uniform 
exposure of cells to nutrients and growth factors, whereby cells inside the pores have 
less access to growth factors. In addition, CultispherTM G cultures resulted in a decrease 
of pluripotency. (Chen et al. 2011) 
The composition of the microparticle material has an effect on the 
outperformance of particles in cell culture studies. The properties of microparticles 
composed of copolymers or polymer blends are affected by the blend ratio. Gabler et al. 
investigated the effect of blend ratio to the resulting PLGA particle size. Particles with 
low PLA content were smaller than particles obtained with the same parameter set with 
higher PLA ratio. In addition, lower PLA proportion led to faster surface erosion of the 
particles. Interestingly, particles with high PLA content showed best results in respect of 
chondrocyte adherency. (Gabler et al. 2007) Thomson et al. also studied the effect of 
blend ratio of PLGA to the resulting particle size with single emulsion based method. 
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Their results were consistent with Gabler et al. The blends rich in PLA produced larger 
particles and were superior for maintenance of the RPE cell viability as well. (Thomson 
et al. 2010) 
4.5. Microparticles in cell culture and tissue engineering 
Cell attachment to the microparticles depends on the chemical composition, surface 
topography, porosity and surface charge of the particles. Furthermore, the diameter of 
the particles and resulting surface affect the number of attached cells. The major 
advantage of microparticles is a relatively large surface area in a relatively small 
volume. For instance, 1 g of CytodexTM 1 microparticles has a surface area of 4400 cm2, 
which corresponds to the surface are of fifty-eight 75 cm2 culture flasks. Thus, the use 
of microparticles in cell and tissue culture is space saving, cost effective and less time 
and labor consuming than conventional 2D culture methods. In addition, serial samples 
can be taken from the cultures without disturbing the cell proliferation. Moreover, 
microparticle cell culture systems allow adjustment of culture conditions, such as 
controlling the composition of the culture media and environmental factors as shear 
force. Besides cell culture system, microparticles have been used in cell behaviour 
studies as well as cell delivery systems to regenerate tissue in trauma sites. (Martin et al. 
2011)  
4.5.1. Microparticles and primary cells 
Several studies have proven that primary cells can be cultured efficiently on 
microparticles and in large scale in bioreactors. In particular bone and cartilage forming 
cells, keratinocytes, hepatocytes and cells for central nervous system have been 
investigated in microparticle culture systems. Furthermore, several microparticle-
expanded primary cells have been used for transplantation purposes in animal studies. 
(Martin et al. 2011; Sun et al. 2011) 
 Microparticles have intrigued in bone graft engineering due to the rapid cell 
growth and expansion on particles. Furthermore, these microparticles can be 
incorporated into larger scaffolds with suitable mechanical stability for transplantation 
purposes.  Interestingly, the shear stress in perfused cultures has been shown to have a 
positive effect on osteogenic cells. (Martin et al. 2011) Osteoblasts and other osteogenic 
progenitor cells have been shown to proliferate on variety of microcarriers, and have 
been used in both in vitro and in vivo investigations. (Qiu et al. 2000; Botchwey et al. 
2003; Barrias et al. 2005) Also chondrocytes have been proven to retain their phenotype 
when cultured and propagated on microparticles. Moreover, chondro-progenitor cells on 
microparticles have been shown to produce tissue-like materials. Microparticles 
composed of materials such as PLA, PLLA and PLGA have been used for cultivation of 
chondrocytes either alone, or embedded inside a hydrogel. The embedded 
microparticles in hydrogels inhibited the uncontrollable movement of the particles, 
  35
whereas microparticles enhanced the mechanical strength of the hydrogel. (Martin et al. 
2011; Hong et al. 2008) 
 Keratinocytes are traditionally cultured on a layer of lethally irradiated mouse 
3T3 fibroblasts that support their growth. Avoiding the need for these feeder cells with 
culturing keratinocytes on microparticles would be advantageous for transplantation 
purposes. Voigt et al. showed that keratinocytes can proliferate on CytodexTM 
microcarriers, and these cell and particle complexes could be cryopreserved. However, 
the CytodexTM are not biodegradable and resulted in scar formation after implantation in 
a mouse model. (Voigt et al. 1999) Keratinocytes have also been cultured on 
biodegradable PLLA, PLGA and commercial CultispherTM microparticles. These 
studies have shown that microparticle culture system supports the growth of 
keratinocytes without mouse fibroblasts. Interestingly, keratinocyte transplantation on 
microparticles has been studied in a clinical study in which autologous human 
keratinocytes were used to treat venous leg ulcers.  Partial or full re-epithelialization 
was seen in all wounds treated with keratinocytes on CultispherTM microparticles. (Liu 
et al. 2004; Martin et al. 2011)  
 In addition to osteoblasts, chondrocytes and keratinocytes, hepatocytes have also 
been vigorously studied in microparticle culture systems. The first reports of hepatocyte 
expansion were reported already in 1986, in which rat hepatocytes were cultured on 
Cytodex 3TM microparticles. The investigators reported prolonged hepatocyte viability 
and function in vitro as well as in vivo. (Demetriou et al. 1986) In addition to expansion 
of cells in vitro and transplantation studies in animal models, microparticles have been 
investigated for the use in bioartificial liver devices (BAL). BALs are bioreactors 
usually composed of a hollow fibre that supports circulating hepatocyte culture. 
Microparticles made of cellulose, chitosan, collagen, gelatin, plastic and PLGA have 
been studied as potential parts of these BAL systems. (Martin et al. 2011; Sun et al. 
2011) 
 Ocular pigment epithelial cells have also been examined in microparticle 
suspension cultures. D’amico et al. were the first to report the culture of RPE cells on 
microparticles. They cultivated successfully mixed bovine retinal pigment epithelium-
choroid cells on Superbeads. The RPE-choroid cells grew well on these microparticles, 
but contained considerably fewer pigment granules per cells. (D’amico et al. 1982) 
Kuriyama et al. cultivated human foetal RPE cells on Cytodex 3 microparticles in 
spinner flasks. They reported substantial increase in cell amount in a week, and also a 
bridging between the particles was seen, which according to the investigators are signs 
for tight cell adhesions. (Kuriyama et al. 1992) Thomson et al. studied blended PLLA 
and PLGA microparticles as suitable carriers for RPE cell transplantation. They seeded 
human RPE cell line ARPE-19 cells on particles coated with different ECM proteins. 
Particles rich in PLLA were superior for maintaining RPE cells viable. Also, laminin 
coating on the surface of the particles improved the RPE cell attachment. (Thomson et 
al. 2010) RPE cells have also been transplanted on microparticles. Oganesian et al. 
transplanted human foetal RPE cells on cross-linked fibrinogen microparticles to the 
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subretinal space of rabbits. A monolayer outgrowth of transplanted human foetal RPE 
cells from microparticles was seen as well as radiating hyperpigmentation around the 
transplanted microparticles. The cells survived in the subretinal space at least for a 
month, and a mild local inflammatory response was detected. (Oganesian et al. 1999) 
Human RPE cells have shown to produce levodopa. This property of RPE cells was 
utilized by Stover et al., who cultured RPE cells from human post mortem eyes on 
gelatin microcarriers and transplanted them to the striatum of six patients with advanced 
Parkinson’s disease. The implanted microparticles and RPE cells were safe and well-
tolerated, and improvements in the motor symptoms of the Parkinson’s disease patients 
were seen. (Stover et al. 2005) 
4.5.2. Microparticles and adult stem cells 
The successful use of microparticles with primary cells has encouraged the use of these 
culture systems as an expansion tool of stem cells for clinical applications. MSCs are 
already in use in clinical studies, but technical problems such as long expansion periods 
have created a need for bioreactors that allow controlling and automation of the cell 
culture conditions. In fact, several studies have proven the ability of MSCs to attach, 
proliferate, and differentiate on microparticles in spinner cultures. For instance, Wu et 
al. were among the first to explore the performance of MSCs in microparticle cultures. 
They showed that the MSCs can be propagated over 10-fold in spinner cultures in 7 
days, and the MSCs maintained their multipotency. (Wu et al. 2003) Especially 
Cultispher-S and Cultispher-G microparticles have been studied with MSCs as well as 
microparticles composed of hydroxyapatite. Besides MSCs, neural stem cells and 
pancreatic stem cells have been studied in microparticle suspension cultures. (Sun et al. 
2011) 
4.5.3. Microparticles and hESCs 
Traditional culture methods of hESCs are impractical or unable to produce necessary 
scale-up of the cells for transplantation purposes. The usefulness of microparticles in 
cell culture has been proven with differentiated cells, but modifying microparticle 
culture system for hESCs is more challenging. (Martin et al. 2011) Fortunately, a few 
research groups have accepted the challenge, and developed microparticle culture 
systems for hESCs.  
 Phillips et al. investigated the attachment and proliferation of hESCs on Hillex 
IITM microparticles in CM collected from hFFs. The cells were seeded on the 
microparticles either as single cells or as small aggregates. Phillips et al. reported that 
majority of the cells attached within 2 hours of cell seeding. The cultures were 
expanded on microparticles for 10 days. Single cell cultures resulted in a 3-fold 
expansion, whereas aggregates doubled the population. According to the investigators, 
the higher yield with single cells suspension might be due to a better coating by cells of 
a greater number of microparticles, therefore taking greater advantage of the surface 
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area. Furthermore, the single cell cultures were easier to passage and they persisted at 
least for 6 passages, whereas aggregated suffered from substantial cell loss and 
sustained only 3 passages. However, both single cells and cell aggregates expressed 
pluripotency markers throughout the culture time on microparticles. (Phillips et al. 
2008) 
 Lock et al. studied the large scale production of hESCs on MatrigelTM coated 
Hyclone microparticles. As Phillips et al., Lock and his colleagues used CM, but their 
medium was collected from MEFs. After cell attachment on particles, the cells were 
transferred to spinner flasks, and the cultures were agitated. Different inoculum 
concentrations were studied and the high hESC seeding concentrations resulted in the 
formation of EB-like structures. Interestingly, the propagation of hESCs in bioreactor 
resulted in 34- to 45-fold increase in the number of hESCs during 8 days. Furthermore, 
the investigators stated that pluripotency markers TRA-1-81, Nanog, OCT 3/4 and 
SSEA4 did not deteriorate significantly during hESC propagation in microparticle 
cultures. (Lock et al. 2009) 
 Nie et al. had a different approach to culturing hESCs on microparticles. They 
modified the surfaces of Cytodex 3TM microparticles with either MEFs or MatrigelTM. 
hESCs were effectively expanded in undifferentiated state on both MatrigelTM-coated 
microparticles and microparticles seeded with a MEF monolayer. However, the 
expansion rate of hESCs on MEF-coated microparticles was slower than in 
conventional culture system, whereas the MatrigelTM-coated microparticles were 
superior to the MatrigelTM-coated tissue culture plates. Furthermore, Nie et al. showed 
in their study, that hESCs can be cryopreserved adherent on the microparticles with a 
higher recovery of undifferentiated cells than after cryopreservation of cells in 
suspension. (Nie et al. 2009) 
 Oh et al. tested hESC propagation in serum-free defined medias Stempro and 
mTeSR® 1. They cultured hESCs on MatrigelTM coated DE 53 cellulose microparticles. 
They showed that this type of culture system allows simple and routine passaging of 
hESCs without differentiation. The expression of plurimarkers such as OCT 3/4, SSEA4 
and TRA-1-60 were similar to those of the control 2D culture. After passaging the 
hESCs on these microparticles, they became fully confluent on day 6. In uncoated DE 
53 microparticles, the cells rapidly colonized the particles, but underwent rapid 
differentiation. Histological analysis showed that hESCs on MatrigelTM coated 
microparticles formed multilayers of cells, and all of the cells still expressed 
plurimarker TRA-1-60. The hESC culture on microparticles resulted in doubling the cell 
yields in 7 days compared to conventional 2D cultures due to the increased surface area 
available. Due to the promising results with hESC culture on microparticles, Oh et al. 
investigated the large scale production of hESCs in spinner flasks. This resulted in a 
superior density compared to static microparticle conditions and over 4-fold yields 
compared to 2D cultures. These hESCs were cultured on microparticles up to 7 weeks 
with continuous expression of plurimarkers. (Oh et al. 2009) 
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 Fernandes et al. reported successful scale-up of hESCs on microparticles in 
feeder- and MatrigelTM-free conditions in continuous agitation. Fernandes and 
colleagues studied CytodexTM 3 microparticles in MEF CM.  They cultured hESCs 
under continuous agitation for 15 days resulting in 2-fold yields compared to static 2D-
cultures. These cells maintained stable karyotype after two weeks of cultivation. 
(Fernandes et al. 2009) Storm et al. focused on the initial seeding parameters of hESCs 
on Cultispher- S microparticles. To improve the cell survival in passaging, they used a 
p160-Rho-associated coiled kinase (ROCK) inhibitor Y-27632. With ROCK inhibitor, 
the cells were successfully passaged as aggregates. 3D cultures of hESCs in MEF CM 
maintained expression pluripotency markers, which in some cases were even higher 
than in conventional 2D cultures. (Storm et al. 2010) 
4.6. Differentiation of hECSs on microparticles 
Even though several studies on culturing hESCs on microparticles have been reported, 
only few research groups have attempted direct differentiation of hESCs towards mature 
cell types on microparticles. Lock et al. differentiated hESCs on collagen coated 
HycloneTM microparticles towards definite endoderm with a medium containing activin 
A, Wnt3a, and low concentration of serum. More than 80% of the differentiated hESCs 
expressed definite endoderm markers, such as forkhead box protein A2 (FOXA2) and 
SOX17, whereas the expression of non-definite endoderm genes was minimal. (Lock et 
al. 2009) Lecina et al. investigated the effect of several microparticles on differentiation 
efficiency of hESCs towards cardiomyocytes. For example, DE 53, CytodexTM 1 and 3, 
FACT and TOSOH-10 microparticles were used for studying the effects of type, size, 
shape and microparticle concentration on the differentiation efficacy. Lecina et al. 
reported that the smaller the beads, the more regular and smaller aggregates were 
formed, which enhanced the differentiation. The hydroxylated metacrylate TOSOH-10 
microparticles with a diameter of 10 μm produced 80% of beating aggregates out of all 
aggregates, threefold cell expansion and yields of 20% of cardiomyocytes. (Lecina et al. 
2010) Leung et al. focused on the influence of agitation on differentiation of hESCs in 
microparticle cultures. They claimed that the mechanical stress caused by agitation 
resulted in downregulation of OCT3/4, mAb 84, and TRA-1-60 plurimarkers. However, 
they concluded that the changes in the differentiation of the agitated cell line does not 
result directly from the shear stress caused by agitation, but rather by signaling effects 
that influence the cells to differentiate resulting in slower growth. (Leung et al. 2010) 
Also, differentiation towards ectoderm has been achieved on Hillex IITM and 
CultispherTM particles. (Phillips et al. 2008) 
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5. MATERIALS AND METHODS 
The practical work in this thesis consisted of two fields, first being the preparation of 
biodegradable microparticles and the optimization of the analysis of prepared particles. 
The second part of the practical work included culturing and differentiation of hPSCs on 
self-prepared and commercial microcarriers. The course of the study is represented in 
Figure 11.  
 
Figure 11. The course of the practical work.  
5.1. Microparticles 
5.1.1. Materials for particle preparation and commercial 
microcarrier 
Biodegradable PLGA granules with the composition of 53/47 PLDLGA from Bio 
Invigor (Bio Invigor Corporation, Taipei, Taiwan) were used for microparticle 
preparation. The PLGA granules were a kind gift from our collaborator professor Loo. 
These copolymer granules had the inherent viscosity (i.v.) of 1.03 dl/g. In addition, 
Purasorb PL 24 PLLA granules with i.v. of 2.51 dl/g were purchased from Purac (Purac 
Biomaterials, Gorinchem, Netherlands). The PLLA had maximum of 0.01 % of residual 
solvent and 0.1 % of residual monomer. Both polymers were used in concentration of 
0.04 g/ml. As comparison, commercial preswollen microgranular cellulose anion 
exchange diethylaminoethyl (DE) 53 microcarriers from Whatman (Whatman 
international Ltd, Kent, UK) were used. These microcarriers are positively charged due 
to the DE tertiary amino groups and possess a small ion exchange capacity of 2 milli-
equivalents per gram of dry materials. DE 53 microparticles are cylindrical in shape and 
have the dimensions of 40 to 50 µm in diameter and 80 to 400 µm in length, and they 
are more commonly used in chromatography due to their anion exchange capacity 
(Figure 9).  
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5.1.2. Preparation of biodegradable microparticles 
Biodegradable PLGA and PLLA microparticles were prepared according to the protocol 
of our collaborator Joachim Loo and his colleagues with slight modifications. The 
preparation protocol was a simple and versatile one-step solvent evaporation technique, 
which was not only quite fast to execute but also economical since complex and 
expensive fabrication equipment were not needed. (Loo et al. 2010)  Figure 12 
illustrates the fabrication protocol of microparticles by a single emulsion process. 
 
 
Figure 12. A Schematic picture about microparticle preparation by a single emulsion 
process. (Bible et al. 2009) 
 
First, a polymer solution was prepared. 200 mg of desired polymer was added 
into 5 ml of DCM (Sigma-Aldrich, St. Louis, MO, USA) and stirred with a magnetic 
stirrer for 2 h at room temperature (RT) until the polymer granules were fully dissolved 
into the solvent. Simultaneously, an aqueous solution of emulsion stabilizer was 
prepared. In this study, 1% PVA solution was used. 500 mg of PVA powder (Bio 
Invigor) was dissolved in 50 ml of deionized water and stirred with a magnetic stirrer 
for 2 h at RT. The prepared PVA solution was sterile filtered with a 0.2 µm filter and a 
syringe.  
5 ml of 1 % PVA solution was added into a glass container, after which 1 ml of 
prepared polymer solution was carefully added on top. Two separate immiscible phases 
were detected. A magnetic stirrer was dropped into the container very gently and the 
container was sealed with either two layers of parafilm or a cork depending on the used 
vessel. Few holes were made into the parafilm so that the fumes formed in the 
preparation process were able to exit the container without tearing the whole parafilm 
layer. In order to optimize the preparation protocol for the equipment and reagents 
found in our laboratory, several glass containers with different shapes and sizes were 
tested in addition to few different magnetic stirrer sticks with distinct dimensions.  
The stirring speed has a huge impact on the size and density of the formed 
particles. The desired particle size in this experiment was approximately from 100 to 
150 µm. To achieve particles of this size, particle preparation paramaters such as 
stirring rate were optimized. The mix of solutions was either stirred with constant speed 
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for 2 h or quickly swung by hand and left still for the rest of the 2 h. In this study, 
stirring speeds of 0 rpm, 120 rpm and 500 rpm were tested. After stirring, the parafilm 
was replaced by a sterile gas mask, and the container was left in fume hood over night 
so that the DCM solvent was fully evaporated from the solution. Next, the particles 
were transferred into 2 ml eppendorfs, approximately 50 mg of microparticles per tube, 
and washed twice with sterile water. In between the washes, the beads were centrifuged 
down with the speed of 6500 rpm for 5 minutes. After the final centrifugation, the pellet 
was resuspensed with 30 µl of sterile water, and the eppendorfs were left open in 
laminar hood for 3 to 4 days to dry. Steps of particle preparation are illustrated in Figure 
13. 
 
 
Figure 13. Pictures about particle preparation. On the left, preparation of polymer and 
emulsion stabilizer solutions. In the middle, mixing of the solutions with a magnetic 
stirrer. On the right, the solvent is evaporated over night by covering the container with 
a sterile gas mask. 
5.1.3. Coating of microparticles 
In order to improve the cell attachment on microparticles, different coatings were tested. 
Prepared PLLA beads and commercial DE53 beads were coated with few ECM 
proteins. For this study, BD MatrigelTM (BD Biosciences, Franklin Lakes, NJ, USA) 
and mouse laminin (Sigma-Aldrich) were chosen. One tube of each particle type (á 50 
mg of particles) was resuspended into Dulbecco’s Phosphate Buffered Saline (DPBS) 
and divided into three 5 ml sterile tubes. The beads were allowed to settle down to the 
bottom of the tube and excess DPBS was removed. Three different solutions for each 
particle type were prepared; BD MatrigelTM dilution (0.33 mg/ml), mouse laminin 
solution (20 µg/ml) and DPBS as a control. The tubes were sealed with caps, and 
parafilm was applied on top after which the beads were coated overnight in a Roto-
Shake shaker at 4 ºC. For the coating, the tubes were attached to a shaker so that the 
solution and microparticles inside the tubes moved from one end of the tube into 
another with a very slow speed (Figure 14).  
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Figure 14. Coating microparticles on a Roto-Shake shaker. 
5.1.4. Autofluorescence and background 
Immunofluorescence and imaging was a major analysis tool in this study. In preliminary 
studies conducted in the ophthalmology group of BioMediTech, a strong background 
with common immunoreagents was detected with the PLGA microparticles. Therefore, 
before cell seeding on the microparticles, the intensity of autofluorescence and 
background with 4’,6-diamino-2-phenylindole (DAPI) were investigated with different 
wavelengths. 
First, autofluorescence of self-prepared and commercial particles was tested. 
Dried self-prepared particles and commercial DE 53 were resuspended into sterile water 
and small amounts of particles were added onto microscope coverslips and excess water 
was removed. A drop of Vecta MountTM without DAPI (Laboratories, Inc., Burlingame, 
USA) was applied on top of the particles, and the samples were covered with cover 
glasses. Excitation wavelengths of 320 nm, 488 nm and 568 nm were inspected, and 
images were taken with Olympus IX 51 Fluorescence microscope (Olympus Europa 
Holding GMBH, Hamburg, Germany).  
In preliminary studies DAPI caused significant background that disturbed the 
analysis of cell attachment and proliferation on microparticles. Therefore the 
background caused by DAPI with different dilutions for all the particles under 
inspection was examined. A dilution series of Vectashield MountTM with DAPI (Vector 
Laboratories, Inc., Burlingame, USA) was prepared according to the Table 3. Dry 
particles were resuspended into sterile water and small amounts of particles were 
transferred to the bottoms of 48-well plate wells. A drop of undiluted mount with DAPI 
or diluted mount with DAPI was applied on top of the samples. The wells were covered 
with cover glasses, and the background with DAPI was analyzed and imaged with 
Olympus IX 51 Fluorescence microscope.  
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Table 3. DAPI dilution series for testing background caused by DAPI. 
 1:10  1:100  1:1000 
30 µl of 
vectashield mount 
with DAPI 
30 µl of 1:10 DAPI 
dilution 
30 µl of 1:100 
DAPI dilution DAPI Dilution series 
270 µl of PBS 270 µl of PBS 270 µl of PBS 
 
5.1.5. Analysis of particle preparation and coating procedures 
The size and shape of self-prepared microparticles were analysed by microscopy with 
Olympus IX 51 fluorescence microscope. Dried particles were suspended into DBPS, 
and transferred to a well of a 48-well plate. Both bright field and fluorescence images 
were taken.  
The success of coating procedure of PLLA and DE 53 particles was verified by 
indirect immunofluorescence staining. In indirect immunofluorescence, the sample is 
first treated with a primary antibody that binds specifically into the investigated 
molecule. Next, the sample is incubated in secondary antibody dilution that binds the 
primary antibodies or their fragments. These secondary antibodies are usually labelled 
with fluorescent molecules which allow the visualization of the inspected molecules 
with fluorescence microscope. In this study, the following protocol was used for 
immunofluorescence stainings. Secondary antibody without primary antibody was used 
as a control. The background of PLLA and DE 53 microparticles with secondary 
antibody was investigated from the same control samples. 
The immunofluorescence protocol for microparticles was carried out in 1.5 ml 
eppendorf tubes. The particles were washed three times with DPBS to remove any 
remainings of the coating dilutions. To block unspecific protein binding, the samples 
were treated with 3% bovine serum albumin in DPBS (BSA-DPBS) for 1 h at RT. The 
primary antibody used for detecting the presence of coating was anti-laminin (Abcam, 
rabbit IgG, 1:100). The primary antibody was diluted into 0.5% BSA-DPBS, and the 
samples were incubated for 1 h at RT. After the incubation, samples were washed three 
times with DPBS. Secondary antibody dilution was also prepared into 0.5 % BSA-PBS. 
In this study, secondary antibody Alexa fluor 568 anti-rabbit IgG (Molecular Probes, 
Invitrogen) was used with dilution ratio of 1:1500. The samples were incubated in 
secondary antibody dilution for 1 h at RT, after which the samples were washed again 
three times with DPBS and once with milli-Q-water. The stained microparticles were 
transferred onto cover glass and a drop of Vecta MountTM without DAPI was applied on 
top. The sample was covered with another cover glass. Imaging and visualization of the 
success of the coating was carried out with Olympus IX 51 fluorescence microscope. 
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5.2. Cell culture methods 
5.2.1. Cells and cell culture material 
hESC lines Regea 06/040 (46, XX) and Regea 08/023 (46, XY) established in former 
Regea Institute for Regenerative Medicine (currently known as BioMediTech) in 
University of Tampere were used. Regea has an approval of the National Authority for 
Medicolegal Affairs Finland to study human embryos (Dnro 1426/32/300/05). In 
addition, the Ethics Committee of Pirkanmaa Hospital District has given a supportive 
statement for Regea for the derivation, characterization and differentiation of hESC 
lines (Skottman/R05116). These hESC lines are derived from early stage embryos that 
could not be used in infertility treatments. The donors of the embryos signed an 
informed consent form and they did not receive any payment. The hiPSC line FiPS 5-7 
derived by Professor Otonkoski’s group at the University of Helsinki was also 
investigated. This hiPSC line was generated from human fibroblasts utilising four 
transcription factors: OCT 3/4, SOX2, nanog, and LIN28. Both hESCs and hiPSCs were 
cultured on top of irradiated hFFs. The cell lines were maintained in serum-free hESC 
medium at + 37 oC in 5 % CO2. The cells were mechanically passaged on to new hFFs 
every 6 to 7 days. (Skottman 2010) 
5.2.2. Feeder-free culturing 
Before seeding cells on microcarriers, the hESCs and hiPSCs were adapted in feeder-
free conditions for 3 to 8 passages. The hESC and hiPSC colonies on feeder cells were 
cut into small pieces with a scalpel and transferred onto growth factor reduced 
MatrigelTM (BD Biosciences) coated 6-well plates (Corning Incorporated, MA, USA). 
The cut pieces were detached carefully as sheet-like pieces. Approximately 150 colonies 
were cut and transferred onto 2 to 3 wells. Serum-free and defined mTeSR®1 media 
(Stemcell Technologies, Grenoble, France) for the feeder-independent maintenance and 
expansion for hESCs in undifferentiated state was used, and the medium was prepared 
according to the manufacturer’s instructions with the modification of adding antibiotics 
(0.5% penicillin/streptomycin, Lonza Group Ltd). The cells were fed with 2 ml of fresh 
medium five days a week and double fed with 4 ml of fresh medium once a week. Prior 
to feeding, the state of the hESC and hiPSC colonies was checked with a phase contrast 
microscope (Nikon Eclipse TE-2000s, Nikon Instruments) or a stereomicroscope 
(Nikon SMZ800, Nikon Instruments).  
The hESC and hiPSC colonies required to be passaged onto new 6- or 12-well 
plates coated with MatrigelTM every 4 to 6 days. For coating, the MatrigelTM was thawed 
on ice. Furthermore, all the pipette tips, well plates and tubes used for the coating 
procedure were cooled in +4 ºC. MatrigelTM was diluted into ice cold DMEM/F-12 
(Gibco, Invitrogen, NY, USA) to final concentration of 0.083 mg/ml. 1 ml of 
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MatrigelTM dilution was added into a well of a 6-well plate and 0.5 ml into a 12-well 
plate well. Well-plates were coated with MatrigelTM overnight at +4 ºC.  
The colonies in feeder-free conditions were ready to be passaged, when the 
centers of the colonies became dense and phase-bright compared to their edges, and the 
adjacent colonies started to merge. Prior to passaging, differentiated colonies and 
regions were removed with a 1000 µl pipette tip or a needle. The removed pieces and 
medium was aspirated and the wells were rinsed with 2 ml of DMEM/F-12. 1 ml of 
dispase (Gibco, Invitrogen) with the concentration of 1.7 U/ml was added into each 
well. The plate was placed at +37 ºC for 7 minutes or until the edges of the colonies 
started to slightly fold back from the bottom of the well, but the colonies still remained 
attached to the plate. The dispase was removed and the wells were gently rinsed with 
DMEM/F-12 to dilute and wash away any remaining enzyme. 2 ml of DMEM/F-12 was 
added per well, and the colonies were scraped off carefully with a scalpel or a 5 ml 
pipette tip so that the colonies stayed as sheets. The detached colonies were transferred 
to a 15 ml falcon tube and the wells were rinsed with 2 ml of DMEM/F-12 to remove 
the remaining colonies. The cell aggregates were centrifuged with Heraus® Biofuge® 
Primo (Kendro, Germany) at 1400 rpm for 5 minutes. The supernatant was removed and 
the cell pellet was carefully resuspended into 1 ml of mTeSRTM 1 media. The hESC and 
hiPSC aggregates were plated evenly to a new well-plate coated with MatrigelTM in 
diverse ratios depending on the cell density.  
5.2.3. Culturing cells on microcarriers 
Before inoculation of the cells on particles, the commercial DE 53 particles were 
autoclaved, and adapted in DPBS overnight at +4oC, whereas the self-prepared PLLA 
particles were surface sterilized with UV-light for 25 min. After sterilization and 
adaptation procedures, the particles were coated in MatrigelTM over night as described 
in Chapter 5.1.3. The coated beads were washed twice with DMEM/F-12 and once with 
mTeSR® 1 medium to remove the excess MatrigelTM dilution. The hESC and hiPSC 
cultures that were seeded on microparticles had been adapted in feeder-free conditions 3 
to 8 passages. Differentiated areas were removed from cultures, and the wells were 
rinsed with DMEM/F-12 to remove the remains of differentiated cells. Next, the cell 
colonies were treated with 1 ml of prewarmed Tryple (Gibco, Invitrogen) for 5 min in 
+37 oC, after which most of the cells had detached as small aggregates. 4 ml of warmed 
DMEM/F-12 was added to inactivate the enzyme, and the cell aggregate suspension was 
transferred into 15 ml falcon tubes and centrifuged with Heraus® Biofuge® Primo 1300 
rpm for 5 min. The supernatant was removed and the cell pellet was resuspended into 
500 µl or 1000 µl of mTeSR®1 media. Cells were calculated with Neubauer Improved 
hemocytometer. A small amount of coated beads was transferred to the bottom of a 24- 
or 96-low cell bind well plates (Corning Incorporated).  Appropriate amount of cells 
was added on to the particles according to the Table 4.  
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Table 4. Used cell to particle ratios and well-plate sizes in cell seeding on 
microparticles. 
Particle type  Well-plate 
m 
(particles) Cell line 
Amount 
of cells 
seeded 
Cell to particle 
ratio Agitation 
DE 53 24 25 mg hESC 06/040 500 000 20 000 cells/mg No 
DE 53 24 25 mg hiPSC 5-7 1 850 000 74 000 cells/mg No 
DE 53 24 25 mg hiPSC 5-7 1 850 000 74 000 cells/mg Yes 
DE 53 96 10 mg hiPSC 5-7 1 000 000 100 000 cells/ mg No 
DE 53 96 10 mg hiPSC 5-7 1 000 000 100 000 cells/ mg Yes 
DE 53 96 15 mg hiPSC 5-7 350 000 23 300 cells/mg No 
DE 53 96 10 mg hiPSC 5-7 1 000 000 100 000 cells/ mg No 
DE 53 96 10 mg hESC 08/023 1 000 000 100 000 cells/ mg No 
PLLA 120 rpm 96 15 mg hiPSC 5-7 350 000 23 300 cells/mg No 
PLLA 120 rpm 96 20 mg hiPSC 5-7 1 000 000 50 000 cells/ mg No 
PLLA 120 rpm 96 15 mg hESC 06/040 139 000 9300 cells/mg No 
PLLA 0 rpm 96 20 mg hiPSC 5-7 1 000 000 50 000 cells/ mg No 
PLLA 0 rpm 96 20 mg hESC 08/023 1 000 000 50 000 cells/ mg No 
 
5.2.4. Effect of agitation on cell attachment and proliferation 
The effect of agitation on cell attachment and proliferation in microparticle suspension 
cultures was investigated for DE 53 particles. During the cell seeding on particles, two 
parallel wells with similar cell to particle ratio were prepared. The other was agitated 
during day 0 and the other one was left still. The agitation was conducted by pipetting 
media up and down with a 1000 µl pipette so that the cells and beads on the bottom of 
the well were mixed. The agitation was repeated once every hour for 8 hours. In 
between the agitation, the cells and beads were allowed to settle down and the cells to 
attach while in contact with a microparticle surface. 
5.2.5. Differentiation of hPSCs into RPE cells on microparticles  
For the differentiation experiment, Regea 08/023 and FiPS 5-7 were seeded on DE 53 
microparticles in a cell to particle ratio of 100 000 cells/mg in 96-well plate wells. The 
cell seeding on microparticles was conducted as decribed previously in Chapter 5.2.3. 
On day 2 after inoculation of cells, the mTeSR®1 medium for maintaining and 
expanding hPSCs was replaced with RPE differentiation medium (DM-). This RPE 
DM- medium consisted of KnockoutTM D-MEM (Gibco, Invitrogen) supplemented with 
15% KnockoutTM Serum Replacement (Gibco, Invitrogen), 2 mM GlutaMaxTM  -1 
Supplement (Gibco, Invitrogen), 1% MEM Non Essential Amino Acids (Lonza), 0.5% 
Penicillin/Streptomycin (Lonza) and 0.1 mM 2-mercaptoethanol (Gibco, Invitrogen). 
Fresh DM- medium was changed three times a week. After two weeks of culturing cells 
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in DM- on 96-well plates, the cells on beads were transferred onto low cell bind 24- 
well plates so that the volume of the medium could be increased. 
5.3. Analysis of cell culture 
5.3.1. Feeder-free culturing 
The well-being of the hPSC lines in feeder-free cultures were analysed by phase 
contrast microscopy. The cells were followed and imaged daily. In addition, the 
pluripotency of Regea 08/023 and FiPS 5-7 was confirmed after 8 passages in feeder-
free cultures with indirect immunofluorescence staining. 
Briefly, the cells were fixed with 4% paraformaldehyde (PFA) for 10 minutes at 
RT, and washed afterwards three times with DPBS. Next, the cells were permeabilized 
with 0.1% Triton® X-100 (4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene glycol) 
(Sigma-Aldrich). The cells were permeabilized for 10 minutes at RT, and washed three 
times with DPBS.  Then, to block any unspecific protein binding, the cells were 
incubated in 3% BSA-DPBS for 1 h at RT. Antibodies against plurimarkers OCT 3/4 
and Nanog were used (Table 4). Primary antibody dilutions were prepared into 0.5% 
BSA-DPBS, and the samples were incubated for 1 h at RT. After primary antibody 
incubation, the samples were washed thoroughly three times with DPBS. As primary 
antibody dilutions, also secondary antibody dilutions were prepared into 0.5% BSA-
DPBS. The samples were incubated in the secondary antibody dilution for 1 h at RT, 
after which they were washed again three times with DPBS. A drop of Vectashield 
MountTM with DAPI was applied on top of the sample, and the sample was covered with 
a cover glass. Samples were stored at +4º C. The imaging was conducted with Olympus 
IX 51 Fluorescence microscope. 
5.3.2. Cell attachment and proliferation on microparticles 
Cell attachment to the microparticle surface and the cell proliferation was analysed with 
indirect immunofluorescence and phalloidin stainings on day 3 and on day 6 or 7 after 
cell seeding on particles. Small samples were taken from each well of microparticle 
suspension cultures. For DE 53, the sample size was approximately 5 mg, and for PLLA 
particles 10 to 15 mg. A similar immunofluorescence protocol was followed as 
described for the analysis of the pluripotency of the cells in feeder-free cultures. The 
staining protocol for microparticles was carried out in a 1.5 ml eppendorf tubes. The 
microparticles with cells on surface were as suspension in the culture medium, not 
attached to any surface. Therefore, after adding reagent solutions, the particles were 
allowed to settle down to the bottom of the tube and the supernatant was removed 
carefully with a pipette.  
 If phalloidin staining was done simultaneously with indirect 
immunofluorescence protocol, phalloidin was added to the secondary antibody dilution 
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mix. First, the solvent in phalloidin was evaporated in fume hood, and phalloidin was 
redissolved into the 0.5% BSA-PBS solution. The used primary and secondary 
antibodies in addition to phalloidin are listed in Table 5 with dilution ratios. DE 53 
beads were transferred onto a superfrost microscope slide. A drop of Vectashield Hard 
MountTM mounting media with DAPI (Vector Laboratories, Inc., Burlingame, USA) 
was applied on top of the sample and the sample was covered with a cover glass. The 
DE 53 samples were stored at +4 oC. Samples were imaged with Olympus BX 60 
Fluorescence microscope. Due to the quite big particle size of investigated PLLA beads, 
they were hard to place between two cover glasses without the mounting media running 
away from the sample. Therefore, a PDMS structure was attached on a superfrost 
microscope slide. The PDMS structure had a hole in the middle, where the sample was 
added. A drop of Vectashield mounting media with DAPI was applied on top of the 
beads, and the samples were imaged immediately after the staining protocol. PLLA 
samples were visualised and imaged with Olympus IX 51 Fluorescence microscope.  
 
Table 5. The primary and secondary antibodies and other stainings used for 
immunofluorescence analysis of the cell culture. 
Stainings Manufacturer Dilution ratio Origin Binds to 
OCT 3/4 R & D Systems  1:400 Goat  A pluripotency marker, nuclear 
Nanog R & D Systems  1:200 Goat  A pluripotency marker, nuclear 
Primary 
Antibodies 
Ki 67 Chemicon  1:500 Rabbit 
A nuclear protein 
associated in cell 
proliferation 
Alexa fluor 
488 anti-goat 
Ig G 
Molecular 
Probes, 
Invitrogen 
 1:1500 Donkey A primary antibody originated from goat 
Secondary 
Antibodies Alexa fluor 
488 anti-
rabbit Ig G 
Molecular 
Probes, 
Invitrogen 
 1:1500 Donkey A primary antibody originated  from rabbit 
Other 
stainings Phalloidin Sigma  1:200   Actin filaments 
 
In case of conducting only a phalloidin staining without primary antibodies for 
the sample, a following protocol was performed. First, the appropriate amount of 
phalloidin was taken into an eppendorf, and dried in a fume hood for 1 to 2 hours.  The 
samples were washed twice with DPBS and fixed in 4% PFA for 10 min at RT. After 
fixation, the samples were washed thoroughly three times with DBPS. The washes were 
followed by a permeabilization in 0.1% Triton® X-100 for 10 min at RT. The phalloidin 
was diluted into DPBS in ratio of 1:10. The samples were incubated in the diluted 
phalloidin for 10 min at RT and washed again three times with DPBS. Then the 
particles were transferred onto a microscope slide and mounted with Vectashield 
MountTM with DAPI. Another cover glass was replaced on top of the sample, and the 
samples were stored at -20 oC. 
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5.3.3. Differentiation of hPSCs into RPE cells on microcarriers 
The appearance of pigmentation was inspected with light microscope in pursuance of 
feedings during the whole culture time in the RPE differentiation medium. The 
maturation of cells was investigated more precisely with gene expression analysis by 
reverse transcriptase polymerase chain reaction (RT-PCR). RT-PCR is a qualitative 
analysis method, which reveals if certain genes are expressed in cells under inspection, 
but it does not give information about the quantities of gene expression levels. In RT-
PCR, first RNA is isolated from the cells, which is followed by a complementary DNA 
(cDNA) synthesis. Finally, the cDNA is amplified using traditional PCR, and the gene 
expression of investigated genes can be visualized using agarose gel electrophoresis. 
After 35 days in DM- RPE differentiation media, samples from both cell lines, 
08/023 and FiPS 5-7, on DE53 were taken. The culture medium was removed, and the 
samples were washed with PBS. The cells were detached from the beads with Tryple. 
The detached cells were separated from the particles by filtration through a 40 µm cell 
strainer after which the samples were washed with PBS, and lysed into RA 1 lysis 
buffer with Reducing Agent tris(2-carboxyethyl)phosphine (TCEP). The lysis buffer 
inactivates RNases, therefore preventing the degradation of RNA during RNA isolation 
protocol. The samples were vortexed twice for 5 seconds, and stored at -70ºC to wait for 
further treatments. The RNA isolation was executed with NucleoSpin® RNA Xs kit 
(Macherey-Nagel, Düren, Germany). In Nucleospin® RNA XS kit the RNA is bound to 
a silica membrane in a column. The lysis buffer used for inactivating the RNase creates 
appropriate binding conditions which favor the adsorption of RNA to a silica 
membrane. However, contaminating DNA also binds to the silica membrane. This DNA 
is removed by a rDNase solution, which is applied directly on the membrane. Washing 
steps with two different buffers purify the sample from salts, metabolites and 
macromolecular cellular components. Pure RNA can be eluted from the silica 
membrane under low ionic strength conditions with RNase-free water. The amount of 
extracted RNA was measured with NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA).  
The isolated RNA was synthesized into cDNA. Mature hESC 08/023-derived 
RPE cells (d196) and pluripotent hiPSC 5-7 (d0) were used as reference. The cDNA 
synthesis into RNA is based on the action of a reverse transcriptase enzyme, which 
translates the RNA into complementary cDNA. The cDNA synthesis was conducted 
with High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA, USA). Briefly, a reagent solution containing the reverse transcriptase enzyme was 
prepared according to the Table 6. 
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Table 6. The reagent solution of high-Capacity cDNA Reverse Transcription Kit for 
cDNA synthesis. 
Reagents Volumes used per one sample 
Sterile water 3.2 µl 
10 x RT buffer 2 µl 
25 x dNTP Mix 0.8 µl 
10 x Rt random primers 2 µl 
Multiscribe Reverse Transcriptase 1 µl 
Rnase inhibitor dilution (10U/ml) 1 µl 
Total 10 µl 
 
 In total 40 ng of isolated RNA was needed for cDNA synthesis per sample. 
Appropriate amount of sample was dilutes into sterile water so that the volume of 
dilution reached 10 µl. 10 µl of the prepared reagent solution was combined with 10 µl 
of the diluted RNA in a reaction tube, thus the total volume of the sample in the tube 
reached 20 µl. The cDNA synthesis was run with a cycle of 10 min at 25 ºC, 120 min at 
37 ºC and 5 min at 85 ºC.  
 After synthesizing the samples into cDNA, the cDNA was multiplied in PCR 
reaction. Four genes were investigated; the housekeeping gene glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), the pluripotency marker OCT 3/4, and RPE 
specific markers BEST and MITF. GAPDH housekeeping gene was used as an 
endogenous control. The genes, their annealing temperatures, primers and product sizes 
are listed on Table 7.  
 
Table 7. The investigated genes in RT-PCR with appropriate primes, annealing 
temperatures and product sizes.  
Gene  
Tannealing 
oC Primers 5' > 3' 
Size of 
the 
product 
GAPDH  GTTCGACAGTCAGCCGCATC 
GAPDH 55 
GAPDH  GGAATTTGCCATGGGTGGA 
229 bp 
OCT3/4-F CGTGAAGCTGGAGAAGGAGAAGCTG OCT 3/4 62 
OCT3/4-R AAGGGCCGCAGCTTACACATGTTC 
245 bp 
Bestrophin-F2 GAATTTGCAGGTGTCCCTGT 
BEST 55 
Bestrophin-R2 ATCCTCCTCGTCCTCCTGAT 
214 bp 
Mitf-F AAG TCC TGA GCT TGC CAT GT MITF 52 
Mitf-R GGC AGA CCT TGG TTT CCA TA 
352 bp 
 
A reagent mix was prepared for each gene. Also controls without the reverse 
transcriptase enzyme were prepared (-RT controls). The reagent solutions for RT-PCR 
are shown in Table 8. 24 µl of the reaction solution was combined with 1 µl of the 
cDNA sample in PCR tubes. RT-PCR was started with a hot start, in which the samples 
were treated 3 min at 95 ºC. The rest of the program run consisted of 38 cycles of 30 s 
at 95 ºC, 30 s at the annealing temperature of the gene, and 1 min at 72 ºC.  In this study 
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a temperature gradient was used from 51 ºC to 62.5 ºC so that the investigated genes 
could be studied in the same PCR synthesis.  
 
Table 8. Reagent solutions for each gene and –RT controls per sample. 
Reagent Sample  -RT control 
H2O 16.6 µl 16.725 µl 
10x buffer -Mg 2+ and + KCl 2.5 µl 2.5 µl 
MgCl 25 mM 1.5 µl 1.5 µl 
dNTP 2 mM 1.25 µl 1.25 µl 
primer-F 5 µM 1.0 µl 1.0 µl 
primer-R 5 µM 1.0 µl 1.0 µl 
Taq polymerase 0.125 µl  - 
 
 The expression of investigated genes was visualized with agarose gel 
electrophoresis. 2.0% agarose gel with a volume of 100 ml was prepared. The samples 
were loaded with 5 µl of 6x loading dye to visualise the loading and migration during 
the electrophoresis, and 20 µl of this sample solution was added to the gel.  A generuler 
dilution with DNA ladder was used as a marker for product size in both ends of the gel. 
The gel was driven with 90 V for 50 minutes, which was followed by imaging the gel 
under UV-light for visualisation of the gene expression bands.  
 53 
 
6. RESULTS 
6.1. Particle preparation 
In this study, biodegradable PLGA and PLLA microparticles were successfully 
prepared by a single emulsion process. Self-prepared particles with different average 
sizes and size distributions were manufactured by changing parameters such as stirring 
speed, size and shape of the vessel, and the size and presence of the magnetic stir bar. 
An optimal particle size for RPE applications is approximately 100 to 150 µm in 
diameter. For PLGA, particles of this size were manufactured without stirring in a 100 
ml glass decanter. In contrast, for PLLA to achieve particles with similar size 
distribution, stirring with a magnetic stir bar with dimensions of 0.7 cm in width and 2 
cm in length was required. Prepared PLLA particles are illustrated in Figure 15. 
Prepared particles and their average size and size distribution in addition to used 
parameters are listed in Table 9.  
 
  
  
Figure 15. Self-prepared PLLA particles with average size of 150 µm (scale bar 200 
µm). 
 
 
Table 9. Prepared biodegradable PLGA and PLLA microparticles by single oil-in-water emulsion process. 
 
 
Material  Stirring speed 
Stirring 
time 
Magnetic stir 
bar Vessel 
Size distribution of 
prepared beads Average size Shape of the particles 
PLGA 0 rpm -  - 100 ml glass decanter 10-150 µm 100  µm 
Spherical, uniform in shape and size. Granules inside 
the beads. Particles were light in bright field images. 
PLGA 0 rpm -  - 25 ml glass erlenmeyer  
only few  smaller than 100 
µm 100 to 150 µm 
Elongated, spherical and balloon shaped. Particles 
were light in bright field images. 
PLGA 120 rpm 2 h 3 cm x 1 cm 50 ml glass bottle From nanoscale up to 100 - 200 µm 10 µm Spherical 
PLGA 120 rpm 2h  2 cm x 0.7 cm 100 ml glass decanter 
 10 to 200 µm lots of 
extremely small beads 
Most of particles 
smaller than 20 µm 
Spherical, wide size distribution. Particles were dark 
and grey in bright field images. 
PLGA 500 rpm o/n (20 h) 3 cm x 1 cm 75 ml glass bottle From nanoscale up to 10 µm Nanoscale Mainly spherical and clear lined. Few donut-shaped and irregular particles. 
PLLA 0 rpm -  - 100 ml glass decanter 100 to 300 µm 150 to 200 µm 
Spherical, uniform in shape and size. Small bubbles 
or granules inside the particles.  
PLLA 0 rpm -   - 100 ml glass decanter Quite narrow size distribution 200 to 300 µm Spherical and quite uniform in size 
PLLA 120 rpm 2 h 2 cm x 0.7 cm 50 ml glass bottle Smallest 10 to 50 µm, bigger ones 100 to 200 µm 50 to 100  µm 
Partly irregular shape, elongated and balloon shaped 
particles detected 
PLLA 120 rpm 2 h 2 cm x 0.7 cm 100 ml glass decanter 10 to 300 µm 100 to 150 µm Spherical. Granules or air bubbles inside the beads 
PLLA 120 rpm 2 h  2 cm x 0.7 cm 100 ml glass decanter 
From smaller than 10 µm to 
300-400 µm 150 µm Spherical 
PLLA 150 rpm 2 h  2 cm x 0.7 cm 100 ml glass decanter 
From smaller than 10 µm to 
300-400 µm 100 to 150 µm Spherical 
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In these experiments, the 100 ml glass decanter vessel and a magnetic stir bar of 
0.7 cm in width and 2 cm in length provided the most favourable circumstances for 
particle preparation. The bottom of the 100 ml glass decanter dish was quite even, 
which allowed the magnetic stirrer to whirl evenly. Also, a magnetic stir bar of this size 
was large enough to produce strong and even whirl, but still small enough to fit into the 
container.  
 Stirring speed of the polymer/PVA emulsion proved to have a major impact on 
the resulting particle size. The faster and stronger the stirring was, the smaller and 
denser particles were formed. In this study, a few stirring speeds were examined; 0 rpm, 
120 rpm, 150 rpm and 500 rpm. With a stirring speed of 500 rpm, the prepared PLGA 
particles were all too small, almost nanoscale. For PLGA, the stirring speed of 120 rpm 
resulted also in too small average size with majority of the particles having a diameter 
around 10 µm. Suprisingly, with PLGA the protocol without stirring resulted in 
beautiful particles with quite even size distribution and average size of the particles 
approximately 100 µm. However, these stirring speeds did not have the same effect on 
prepared PLLA particle size. In general, the same stirring speeds produced larger PLLA 
particles than PLGA particles. With stirring speed of 120 rpm, PLLA particles with 
average size of 100 to 150 µm were formed. Quite large PLLA particles were prepared 
without stirring; the average size was between 200 to 300 µm, and the largest particles 
detected had diameters from 400 to 500 µm. Figure 16 illustrates the size and 
appearance of the self-prepared particles. 
 
Figure 16. Size and appearance of self-prepared PLGA and PLLA particles with 
different stirring speeds. Scale bar 100 µm. 
 
 Without any stirring with a magnetic stirrer stick, smaller size distribution was 
seen. The beads were rather uniform in size and shape with lower stirring speeds. In 
contrast, the higher the stirring speed was, the wider was the size distribution and also 
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more variation in shape of the particles was seen. In addition, with higher stirring speeds 
the formed particles had more bubbles and granules inside the beads. Furthermore, the 
particles formed with rougher agitation looked darker in bright field images than 
particles formed without stirring. An uneven whirl in stirring resulted in particles with 
irregular shapes; balloon shaped, donut-like and elongated particles were detected 
(Figure 17). To produce regular spherical particles with single o/w emulsion process 
seems to require fresh polymer and surfactant solutions.  
 
 
Figure 17. Irregular structures of self-prepared PLLA and PLGA particles caused by 
uneven stirring. Scale 200 µm.  
6.1.1. Autofluorescence and background 
The self-prepared PLGA particles emitted quite strong autofluorescence with 
investigated excitation wavelengths of 320 nm, 488 nm and 569 nm. For PLGA 
particles, the autofluorescence was strongest with the wavelength of 320 nm (UV), but 
the difference between 320 nm and the other examined wavelengths was not that 
significant. In addition, also the unprocessed PLGA granules emitted strong 
autofluorescence with all the investigated wavelengths. The commercial DE 53 particles 
gave out autofluorescence with all the wavelengths under inspection. Similar to PLGA 
particles, the autofluorescence for DE 53 was strongest with the wavelength of 320 nm. 
However, the intensity of the autofluorescence emitted by the DE 53 particles was much 
weaker than the autofluorescence of the PLGA particles. In contrast to the PLGA and 
DE 53 particles, the PLLA particles did not show autofluorescence with any of the 
wavelengths in question.  
 DAPI caused background with all examined particles. Despite, the background 
with DAPI was strongest for the PLGA particles. Interestingly, for PLLA and DE 53 the 
background with DAPI was tolerable and did not prevent imaging with short light 
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exposure times. The DAPI dilution series was investigated for all the particles. Even 
with dilutions of 1:1000, DAPI caused significant background for PLGA particles. For 
PLLA, there was no difference between different DAPI dilutions. The results of 
autofluorescence and background experiment are listed in Table 10.  
 
Table 10. Autofluorescence of self-prepared and commercial microparticles and 
background caused by secondary antibodies.  
Material PLGA  PLLA DE 53 
Autofluorescence 
with 320 nm   + + + + -  + + 
Autofluorescence 
with 488 nm  + + + -  + 
Autofluorescence 
with 568 nm  + + + -  + 
Background with 
DAPI  + + + +  +  + 
Background with 
DAPI 1:10  + + + - + 
Background with 
DAPI 1:100  + + - - 
Background with 
DAPI 1:1000  + + - - 
Background with 
secondary Abs Not tested -  + 
 
6.1.2. Coating of microparticles 
Self-prepared PLLA particles and commercial DE 53 microcarriers were coated with 
mouse laminin and MatrigelTM. PLGA was left out of the coating experiment due to its 
strong autofluorescence feature. Both examined particle types were successfully coated 
with investigated ECM dilutions. Coating of DE 53 particles with laminin resulted in 
beautiful uniform coating, which lined the whole surfaces of the particles. The coating 
was rather thick, and almost all DE 53 beads were fully covered with laminin matrix. 
Also MatrigelTM coating for DE 53 particles resulted in uniform layer around the 
particles. However, the laminin coating was thicker compared to the MatrigelTM and 
resulted in stronger fluorescence when visualised and imaged laminin and matrigel 
samples simultaneously with same exposure times.  
 In contrast, for PLLA the coating protocol with both ECM dilutions resulted in 
only partly coated particles. The coating was not a uniform layer. Instead, areas and 
spots of coating were seen around the particles. PLLA particles with two different 
average sizes were studied; 0 rpm (200 to 300 µm) and 120 rpm (100 to 150 µm). For 
both particle sizes the outcome of the coating was similar. All in all, the success of 
coating was much better for DE 53 particles, and laminin proved to be slightly better 
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coating matrix than MatrigelTM. The success of coating procedures for different particle 
types is illustrated in Figure 18.  
 
Figure 18. Immunofluorescence characterization of laminin and MatrigelTM coatings on 
self-prepared and commercial microparticles using antibody against laminin (red).  
Scale bar 200 µm. 
6.2. Culturing hPSCs in feeder-free conditions 
All examined cell lines, Regea 06/040, Regea 08/023 and FiPS 5-7, were cultured and 
maintained in feeder-free conditions from 4 to 8 passages (Table 11). The cell lines kept 
their undifferentiated appearance through their adaption period in feeder-free 
conditions. Every line under inspection needed time to adapt into feeder-free conditions 
for at least 3 to 4 passages before they started to proliferate and expand in such amounts 
that they could been split in ratios of 1:2 and 1:4.  
 Too small or too large cell colony densities in culture wells led to differentiated 
cultures and poor cell proliferation. With optimal density, the cell colonies remained 
undifferentiated and grew rapidly into large and clear lined colonies. If there were areas 
where the colonies were too close to one another, the colonies differentiated forming 
follicle like structures. With low cell colony density, the cells did not proliferate in such 
amounts that they could be split. Time window for passaging hPSCs in feeder-free 
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conditions was very narrow. In this experiment, the cells were passaged usually 4 or 5 
days after the previous splitting, depending on the cell density in wells.  
 
Table 11. Cell line passages when transferred from feeders into feeder-free cultures and 
passages adapted in feeder-free before seeding cells on microparticles. 
Cell line Passage   
Passages kept in feeder-free 
before seeding cells on 
microparticles 
06/040 p94 5 
06/040 p100 4 
08/023 p39 5 to 8 
 5-7  p94 5 
 5-7  p98 4 
 5-7  p101 5 to 8 
 
After transferring cells into feeder-free from feeder cells, lots of cell material 
was lost due to a low attachment of cut cell sheets into MatrigelTM coated wells. Instead, 
a big portion of transferred cell pieces formed EB-like structures. These unattached 
pieces were removed 1 to 2 days after transferring hPSCs into feeder free. In addition, 
in the first 2 to 3 passages in feeder-free, there were quite many differentiated areas, 
which needed to be removed to keep the cultures as pure undifferentiated hPSCs. Also, 
few fibroblast-like cells and colonies were seen growing out of stem cell colonies 
during the first few passages in feeder-free conditions. Differentiated colonies, 
fibroblast outgrowth and merging colonies are illustrated in Figure 19. 
On first day after passaging the cells in feeder-free, the colonies were very 
small. In addition, the colonies possessed a smooth, clear lined and mainly spherical 
appearance. The edges of adjacent colonies were far a part from one another. 
Interestingly, lots of single cells were seen on day 1 after passaging in all cell lines. 
Especially hiPSC line 5-7 had many of them after every passage. On days 2 to 3 after 
passaging, the colonies started to grow. They were still clear-lined, smooth and distinct 
from one another. On day 3, few colonies with denser middles were detected. However, 
on day 4 more dense centers had appeared. The colonies were also so large that they 
started to merge with adjacent colonies. By the day 5 after passaging, most of the 
colonies started to have denser centers with granule-like appearance in light microscope. 
The appearance of colonies in different time points is represented in Figure 20. Also, the 
colonies were so large and merged that in some parts they resembled a large uniform 
cell sheet. At the latest in this point, the cultures were passaged onto fresh MatrigelTM 
coated well-plates.  
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Figure 19. A. An undifferentiated hESC colony in feeder-free conditions. B. A 
differentiated hESC colony in feeder-free conditions. C. Merging hiPSC colonies in 
mTeSR®1. D. Fibroblast outgrowth from a hESC colony in feeder-free conditions. Scale 
bar 500 µm. 
 
 
Figure 20. hESC 06/040 p94+4 and FiPS 5-7 p94+3 in feeder-free conditions. Scale 
bar 500 µm. 
 
All the examined cell lines did not prefer the feeder-free environment. Out of the 
three studied cell lines, Regea 06/040 performed quite poorly when cultured in mTeSR® 
1 medium. The cell material was quite impure through out the culture time in feeder-
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free conditions even though the differentiated areas were removed regularly. Despite the 
hESC line 06/040 was successfully maintained in feeder-free conditions up to 5 
passages, the cultures did not proliferate in such amounts that it could have been split 
and increased the cell volume in cultures. On the contrary, FiPS 5-7 and Regea 08/023 
lines both grew well in feeder-free conditions. They maintained they undifferentiated 
nature throughout the culture time in feeder-free, and proliferated in large quantities. 
FiPS 5-7 and Regea 08/023 also expressed pluripotency markers OCT 3/4 and Nanog 
after 8 passages in feeder-free environment (Figure 21). However, the intensity of these 
pluripotency markers when imaged with fluorescence microscope was rather low, and 
quite high light exposure times were required to be able to visualize these markers. 
 
 
Figure 21. Pluripotency of hESC and hiPSC lines in feeder-free conditions. Scale bar 
200 µm. 
6.3. Attachment and proliferation of hPSCs on 
microcarriers 
Cell lines 06/040, 08/023 and FiPS 5-7 were transferred on to self-prepared MatrigelTM 
coated PLLA 0 rpm particles with an average particle diameter of 200-300 μm, 120 rpm 
particles with an average diameter of 100 to 150 μm, and on commercial DE 53 
microcarriers. The cells had been adapted into feeder-free conditions from 4 to 8 
passages before cell seeding on microparticles. All cell lines attached and proliferated 
on DE 53 particles depending on the cell to particle ratios. However, the cells attached 
very poorly to the PLLA beads of both sizes and the cell amount on PLLA particles did 
not increase. The appearance of microparticles in culture systems is illustrated in Figure 
22. 
 
 62 
 
 
Figure 22. A. FiPS 5-7 on DE 53 and B. 06/040 on PLLA 0rpm in a bottom of a 96-well 
plate well. Scale bar 200 µm. 
 
 The cell attachment on particles was analysed with phalloidin and DAPI 
stainings. DAPI staining showed the attachment of cells on the surface of the 
microparticles. In all day 3 samples of cells on DE 53, quite many DAPI positive cells 
were seen. Furthermore, there were phalloidin positive cells in all day 3 samples of 
hPSCs on DE 53 with beautiful elongated shapes spreading and growing along the 
particle surface. Interestingly, it seemed that the cells entangled around the beads with 
their extension. The cells were attached quite evenly on the DE 53 particles, but some 
clusters of cells were also seen in between the particles. Cell attachment on commercial 
DE 53 microparticles is represented in Figure 24. 
Compared to the DE 53, the cell attachment on the PLLA particles was nearly 
non-existent. Only few cells had attached on both 0 rpm and 120 rpm PLLA particles. 
The attached cells on the particles were mainly as small clusters. In addition, there were 
only couple of phalloidin positive cells visualized on PLLA microcarriers. In addition, 
an interesting phenomenon was seen in all PLLA samples; the cells had formed EB-like 
cell clusters (Figure 23). Almost all the cells in these cell clusters were phalloidin 
positive. In few of these clusters, smaller PLLA particles were trapped inside, but the 
cells did not seem to grow on them. The cell attachment on PLLA particles in different 
timepoints is illustrated in Figure 25. 
 
 
Figure 23. EB-like cell structures in PLLA cultures. A. A bright field image. B. DAPI 
(blue) and phalloidin (red) stainings. Scale bar 100µm. 
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Figure 24. Cell attachment and proliferation on DE 53 particles. DAPI (blue) and 
phalloidin (red) stainings. Scale bar 100 µm. 
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Figure 25. Cell attachment and proliferation on PLLA 0 rpm and 120 rpm particles. 
DAPI (blue) and phalloidin (red) stainings. Scale bar 200 µm. 
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 While inspecting the day 6 and 7 samples of the DE 53 beads, a clear increase in 
cell amount on particles was seen. Also, the number of phalloidin positive cells had 
increased. In contrast, there was no increase in cell amount on the PLLA 0 rpm and 120 
rpm particles. The amount of proliferating cells on the DE 53 was inspected by Ki67 
staining. As result, there were many Ki67 positive cells on these commercial 
microcarriers. The beautiful phalloidin stuctures on DE 53 particles are shown in Figure 
26. 
 
 
Figure 26. Cytoskeletons of hiPSCs and  hESCs on DE 53. A. 5-7 d7. B. 08/023 d7. 
DAPI (blue) and phalloidin (red) stainings. Scale bar 50µm. 
 
The pluripotency of the cells on microparticles was examined with OCT 3/4 and 
Nanog stainings on day 6 or 7. Visualization of these plurimarkers in the DE 53 and the 
PLLA samples was extremely challenging. The intensity of the fluorescence of 
plurimarker positive cells was so low that the background of microparticles almost 
eclipsed the signals completely. With careful inspection, the OCT 3/4 positive cells 
were visible for eye with 20-fold magnification in the DE 53 samples (Figure 27), but 
no Nanog positive cells were detected. However, to be able to take images of these OCT 
3/4 positive cells, long light exposure times were required. Yet, with these long light 
exposure times the autofluorescence and secondary antibody background grew so 
immense that the plurimarker positive cells were challenging to image. On PLLA 
particles, no positive cells for the inspected plurimarkers were detected.  
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Figure 27. Pluripotency of hPSCs on DE 53 in feeder-free conditions. A. OCT 3/4 
positive and B. DAPI stained FiPS 5-7 cells on DE 53 particles on d6. C. OCT 3/4 
positive and D. DAPI stained Regea 08/023 cells on DE 53 particles on d7. Scale bar 
100 µm. 
 
 The effect of agitation on cell attachment and proliferation was examined with 
DE 53 particles in 24-well plate and 96-well plate wells. The agitation had no influence 
on the amount of attached cells on particles, rather it affected the distribution of the cells 
on particles. In non-agitated wells, the cells were partly on the other sides of the 
particles whereas in agitated wells, the cells were quite evenly distributed around the 
DE 53 microcarriers. Furthermore, in non-agitated wells there were many tight and 
large aggregates of particles, which did not loosen regardless of vigorous pipetting. The 
effect of agitation is illustrated in Figure 28. During these experiments with DE 53 
particles, it was also detected that more cells attached on particles when smaller well 
plate size was used. There was much more cells on beads in 96-well plate samples than 
the ones in 24-well plates with similar cell to particle ratio. Furthermore, in 96-well 
plate samples there was also much more phalloidin positive cells compared to parallel 
samples in 24-well plates.  
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Figure 28. The effect of agitation and well plate size on cell attachment on DE 53 
particles. DAPI (blue) and phalloidin (red) stainings. Scale bar 200 µm. 
 
The cell to particle ratio seemed to have a huge impact on the number of 
attached and phalloidin positive cells. The larger the cell to particle ratio was, the more 
cells had attached on particles and more phalloidin positive cells were detected. The 
best attachment and proliferation on DE 53 particles was achieved with cell to particle 
ratios of 100 000 cells/mg and culturing the cells in 96-well plate wells. The results of 
cell seeding and proliferation on DE 53 particles and PLLA beads are listed in Table 12.
Table 12. Attachment and proliferation of hPSCs in feeder-free conditions on microcarriers. 
 
Particle Cell line Well-plate 
Cell to particle 
ratio (cells/mg) Agitation Cells attached d3 
Phalloidin 
positive cells 
Increase in cell 
number on d6 or d7 Pluripotency 
DE 53 06/040 24 20 000 No  + +  +  + OCT 4 positive  
DE 53  5-7 96 23 300 No  +  +  + OCT 4 positive  
DE 53  5-7 24 74 000 No  + +  +  + + OCT 4 positive  
DE 53  5-7 24 74 000 Yes  + +  +  + + OCT 4 positive  
DE 53  5-7 96 100 000 No  + + +  ++  + + + OCT 4 positive  
DE 53  5-7 96 100 000 Yes  + + +  ++  + + + OCT 4 positive  
DE 53  5-7 96 100 000 No  + + +  ++  + + + Nanog negative 
DE 53 08/023 96 100 000 No  + + + +  + + +  + + + OCT 4 positive  
PLLA 120 rpm 06/040 96 9300 No  +  -  - OCT 4 negative 
PLLA 120 rpm  5-7 96 23 300 No  +  +  - OCT 4 negative 
PLLA 120 rpm  5-7 96 100 000 No  +  -  - Nanog negative 
PLLA 0 rpm  5-7 96 100 000 No  +  -   + Nanog negative 
PLLA 0 rpm 08/023 96 100 000 No  +  +  - 
 
Nanog negative 68 
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6.4. Differentiation of hPSCs into RPE cells on 
microcarriers 
Pigmented areas were detected in both investigated Regea 08/023 and FiPS 5-7 cell 
lines 15 days after starting the diffentiation protocol. The pigmented cell clusters were 
very small, but they were clearly on the surface of the commercial DE53 particles. The 
amount of pigmented cell clusters increased with the time, and by the day 35 there were 
approximately 10 to 15 small pigmented areas in both cell lines. During the 
differentiation time of 5 weeks, the cells formed EB-like structures, where the DE 53 
particles were trapped inside the cell clusters. The cell and particle aggregates became 
so tight that they did not deattach with vigorous pipetting. After 35 days in 
differentiation, almost all the particles and cells were in EB-like stuctures, and hardly 
any loose particles were seen.  
The differentiation of stem cells into RPE on DE 53 particles was also 
investigated on gene expression level. The RT-PCR showed that both cell lines express 
BEST and MITF genes, which are markers for RPE maturation. In addition, the 08/023 
line was positive for OCT 3/4 plurimarker. Interestingly, the hiPSC 5-7 d0 reference 
sample for plurimarker also showed MITF expression. The –RT controls were all 
negative. The results of gene expression analysis with RT-PCR are illustrated on Figure 
29. 
 
 
Figure 29. hPSCs express RPE specific markers on gene expression level after 35 days 
of differentiation. 
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7. DISCUSSION 
Degenerative diseases of the retina affect millions of people worldwide. For instance, 
AMD is the leading cause of blindness in the elderly in the developed countries. 
(Finnish Federation of the Visually Impaired 2011) Today, these degenerative diseases 
are incurable, and the current treatments only delay the disease progression. Cell 
transplantation is considered to be a potential treatment for these retinal degenerations. 
(Binder et al. 2002) hPSCs are considered to be potential cell sources, especially for the 
treatment of dry-form of the AMD. However, currently the field of tissue engineering is 
battling againts sufficient cell production for transplantation and research purposes. The 
current maintaining methods for hPSCs limit their production in large-scale. 
Furthermore, the differentiation of these cells into RPE cells is unefficient and results in 
low yields of mature cells. (Rowland et al. 2011) 
In this thesis, the hPSCs were cultured on 3D microparticle cultures in order to 
improve the efficacy of differentiation of stem cells into RPE cells. In addition, the 
suitability of microparticle culture systems for maintenance of stem cells in feeder-free 
conditions was investigated. Self-prepared PLGA and PLLA microparticles were 
investigated in addition to commercial DE 53 microparticles. The shape and size of the 
self-prepared particles as well as the cell attachment and proliferation on microparticles 
were analysed with microscopy and immunofluorescence. RT-PCR analysis was also 
carried out for inspecting the differentiation of hPSCs into RPE cells in microparticle 
culture system. 
7.1. Particle preparation 
The single emulsion process is rather easy, fast and cost effective way to produce large 
amounts of microparticles with different sizes (Lasselle et al. 2007; Gabler et al. 2007). 
In this thesis, biodegradable microparticles of PLGA and PLLA were prepared with a 
single emulsion method according to the protocol of Loo et al. (Loo et al. 2010). Similar 
emulsion-based protocol has been studied previously with slight modifications for the 
preparation of PLGA and PLLA microparticles. (Gabler et al. 2007; Bible et al. 2009; 
Thomson et al. 2010) 
The effect of the stirring rate in the resulting particle size in emulsion-based 
methods has been widely reported. (Lassalle et al. 2007) In this study, the higher the 
stirring rate, the smaller was the average size of the particles. Furthermore, with higher 
stirring rates, the size distribution of the particles grew resulting in more heterogenous 
particles according to their size. The outcome was always a mixed population of 
different-sized microparticles, never homogenous and uniform. By only changing the 
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stirring rate and keeping the other parameters constant differently sized microparticles 
were prepared. The shape and size of the vessels used in particle preparation had an 
impact on the nature of the whirl in stirring. Most of the studied vessels had a sweeping 
bottom, which made the stirring uneven. Particles prepared in these vessels ended up to 
have irregular shapes, such as donut-like and balloon-like. With constant and even 
stirring, the particles were more uniform in size and shape, which is a strong indication 
of the importance of stirring in emulsion based particle preparation method. Thus, the 
stirring affects not only the size of the prepared particles, but also the shape. In this 
study, the best outcome was achieved with a 100 ml decanter. However, the absence of 
a permanent and solid lid of the decanters exposed the preparation process for possible 
impurities and contaminations. A contamination inside a particle would result 
eventually in a contamination of the cell culture. Another source of impurities is the 
solvent itself. DCM is toxic for cells, and residuals in particles might lead to extensive 
cell death in cultures. In this study, the DCM was removed by evaporating overnight. 
This does not quarantee that all the solvent is removed and the prepared particles might 
include great amount of solvent residuals. In this study, no analysis was performed to 
see if there are many residuals left in the particles. In the future, nuclear magnetic 
resonance spectroscopy could be used for detecting complete DCM removal from the 
prepared microparticles. 
 The characteristics of the microparticles prepared by the solvent evaporation 
technique, especially the size, have been shown to be affected by the concentration of 
the polymer and polymer blend ratio. (Thomson et al. 2010) The largest particles 
prepared in this study had diameters between 300 to 400 µm. These large particles were 
obtained with no stirring. In fact, this is the largest size of particles that could be 
fabricated with the studied concentrations of PLGA and PLLA. If bigger particles are 
desired, the concentrations of the polymer solutions need to be increased. In the other 
studies with PLGA and PLLA microparticles, lower concentrations have resulted in 
smaller microparticles with more narrow size distribution whereas with higher 
concentrations larger particles with wider size distributions are obtained. A more narrow 
size distribution would be useful in order to achieve reproducible and homogenous 
culture conditions. (Gabler et al. 2007; Thomson et al. 2010) The concentration of the 
polymer in the solvent used in this experiment was rather low. Nevertheless, the 
resulting size distribution was quite large, which is in contradiction with the previous 
results of Thomson et al. and Gabler et al. However, in this study, there was no other 
investigated concentration as control to which the used concentration and resulting size 
distribution could have been properly compared to. Therefore, based on this study, 
nothing can be said about the effect of concentration on the resulting size distribution. 
The self-prepared PLLA particles were constantly larger than the PLGA particles 
produced with the similar stirring rates and other parameters. This is most probably due 
to the more hydrophobic nature and higher i.v. of PLLA. Similar trend have previously 
been reported for PLLA and PLGA microparticles prepared with single emulsion 
method. (Gabler et al. 2007; Thomson et al. 2010) 
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 The surface properties of the growth substrata, such as topography and 
hydrophilicity, influence the cell attachment. In this study, the prepared particles were 
analysed with light microscopy, which reveals the rough shape and size of the particles, 
but does not reveal anything about the surface structure and porosity. Commonly, the 
surface topography of microparticles has been evaluated with scanning electron 
microscopy (SEM). SEM analysis has shown that increasing concentrations of PLLA in 
blended particles result in more rough surface structure. (Bible et al. 2009; Thomson et 
al. 2010) Besides surface topography, the hydrophilicity of the polymer surface is very 
important for cell attachment. For instance, water-contact-angle technique has been used 
for evaluating the changes in hydrophilicity of PLGA microparticles. (Bible et al. 2009) 
In order to evaluate and characterize the self-prepared particles and their suitability for 
cell culture purposes in more detail, SEM analysis and water-contact-angle studies 
should be carried out.  
 Immunofluorescence imaging of biomaterials is often disturbed by 
autofluorescence of the investigated polymer and other distracting optical phenomena. 
This is a major disadvantage in analysis of the cells attached on the biomaterial 
surfaces. The phenomenon can be very intense and it can inhibit the detection of labeled 
molecules. (Jaafar et al. 2011) Indeed, the autofluorescence was found very disturbing 
with self-prepared and commercial microparticles also in the experiments of this thesis. 
Especially PLGA microparticles emitted strong autofluorescence with all the 
investigated wavelengths, whereas hardly any or tolerable autofluorescence was seen 
with PLLA and DE 53 particles. The autofluorescence of PLGA could be possible 
reduced by changing the composition of the polymer. Since PLLA did not emit strong 
autofluorescence in this study, the increase of lactide/glycolide monomer ratio could 
result in reduced autofluorescence of the copolymer. Also background with nuclear 
stain DAPI proved to be disturbing. In order to improve the imaging of the biomaterials, 
methods to diminish these phenomena need to be applied. For instance, a fluorescence 
dye with excitation and emission wavelengths outside the spectra of autofluorescence 
could be chosen (Van de Lest et al. 1995), the polymer scaffold could be sectioned into 
thin slices (Sung et al. 2004), or alternatively, alkaline phosphatase conjugation of the 
antibodies could be used to eliminate the need for fluorescence microscopy (Alperin et 
al. 2005). Unfortunately, most of these techniques are very hard to execute with 
microparticles and commonly used antibodies. However, a simple material treatment 
method with a Sudan Black (SB) autofluorescence quenching molecule could provide a 
solution. The studies have shown that the treatment with SB inhibits the optical 
phenomena of several biodegradable polymers without interfering with 
immunofluorescence imaging of the labeled cells cultured on these polymers. (Jaafar et 
al. 2011) 
 Several studies have reported improved cell attachment on particles coated with 
ECM proteins, such as laminin, MatrigelTM and fibronectin. (Bible et al. 2009; Lock et 
al. 2009; Nie et al. 2009; Oh et al. 2009; Thomson et al. 2010) Despite the popularity of 
ECM coatings on particles, only few of the studies report confirmation of the presence 
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of the coating. Bible et al. verified the success of fibronectin coating on PLGA particles 
by immunofluorescence. (Bible et al. 2009) In this thesis, similar approach was applied 
to confirm the success of laminin and MatrigelTM coatings on self-prepared PLLA and 
commercial DE 53 particles. The laminin coating appeared to be slightly better in both 
particle types compared to MatrigelTM. However, the primary antibody used was anti-
laminin, whereas MatrigelTM is a mix of ECM proteins of which laminin is only one 
component. Therefore, the success of MatrigelTM might actually be better than 
visualized in this experiment. In general, the success of both coatings was rather poor on 
PLLA particles. There were spots and larger areas of coating, but the majority of the 
particle surfaces were lacking the protein layer. These results are similar to those 
reported by Bible et al. for PLGA particles. (Bible et al. 2009) The poor attachment of 
the coating might be due to the rather hydrophobic nature of the PLLA surface. In 
contrast, both coatings on commercial DE 53 microparticles were nicely covering the 
particles. The more successful coating with DE 53 is probably due to the positive 
surface charge of the particles, which attract the negatively charged ECM proteins. In 
order to improve the success of coating for PLLA particles, the hydrophilicity or 
polarity of the PLLA surface should be increased. For example, functionalization of 
PLGA and PLLA surfaces by plasma polymerization or by surface aminolysis have 
resulted in improved coating efficacy. (Hong et al. 2005; Bible et al. 2009) 
 The single emulsion method proved to be a very simple, fast and convenient 
procedure to prepare biodegradable microparticles in practise. Microparticles with 
different sizes were prepared by simply changing the stirring rates during the fabrication 
process. However, more precise and detailed characterization of the prepared particles 
should be conducted. Furthermore, the surfaces of prepared particles should be modified 
in order to increase the attachment of ECM proteins. A major limitation of the studied 
materials, especially PLGA, is the strong autofluorescence of the polymers, which 
disturb the analysis of cells grown on the surfaces of the particles. Thus, methods to 
decrease these disturbing phenomena should be investigated. 
7.2. Culturing hPSCs in feeder-free conditions 
Currently, most of the stem cell lines are maintained on feeder cells. However, 
maintaining stem cells on feeders is both laborious and expensive. Furthermore, the 
effect of feeder cells on stem cells is not yet completely unravelled. (Hakala et al. 2009) 
In this study, we followed the protocol of Oh et al. who cultured hESCs on commercial 
DE 53 particles in feeder-free conditions. (Oh et al. 2009) However, transition of cells 
straight from feeders and from 2D structure into feeder-free 3D cultures with different 
media could be fatal for the sensitive hPSCs. Therefore, the hPSCs were adapted in 
feeder-free conditions in 2D cultures for several passages before seeding cells on self-
prepared PLLA and commercial DE 53 particles. Despite laminin proved to be a slightly 
better coating material compared to the MatrigelTM, MatrigelTM was used with the 
feeder-fee culture medium mTeSR®1. The mTeSR®1 feeder-free culture system has 
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been optimized for MatrigelTM and changing this matrix to another would have required 
optimization of the culture conditions. Furthermore, MatrigelTM has been shown to be 
essential for stable long-term propagation of hESCs in microparticles (Chen et al. 2011). 
 The investigated feeder-free method supported the growth of undifferentiated 
hPSCs. All the investigated cell lines were maintained successfully in mTeSR®1 media 
and on MatrigelTM coated wells for 4 to 8 passages. However, during the transmission of 
the cells into feeder-free, lots of cell material was lost. In some cases, even half of the 
cut pieces did not attach to the new growth substrata, instead they formed EB-like 
structures. This poor attachment of cell pieces could result from cutting the pieces too 
large, which might hinder the attachment of cells. In addition, the lack of growth factor 
secreting feeder cells and transfer into probably less abundant medium might be too 
shocking for some of the cells. Moreover, the cells were seeded on MatrigelTM, which 
suffers from batch-to-batch variation due to its origin in mouse Engelbreth Holm-
Swarm sarcoma cells.  
In all cell lines, a lag phase in the growth and proliferation was seen after 
transferring the cells into feeder-free cultures. This lag phase usually took 3 to 4 
passages during which the cell amount hardly increased. After the initial lag phase, the 
cells proliferated nicely. Similar lag phase with stem cultures in mTeSR®1 medium has 
been previously reported. (Ojala 2009) The lag phase might result from too small cell 
seeding density in wells when transferring cells to feeder-free conditions. Furthermore, 
the cells might need time to adjust to the new culture conditions. However, this 
adjustment might be dangerous if it involves changes in gene expression and 
chromosomal level. hESC lines derived and cultured in feeder-free cultures have shown 
genetic instability and chromosomal abnormalities. These abnormalities in karyotypes 
are not welcome when maintaining stem cell lines. (Ludwig et al. 2006a; Catalina et al. 
2008) In this thesis, the stem cells were cultured in feeder-free conditions for maximum 
8 passages. This is a rather short time scale to evaluate the success of a culture method, 
and no conclusion of long-term support of undifferentiated stem cells in this feeder-free 
culture system can be drawn based on this study. However, long-term cultivation of 
stem cells in mTeSR® 1 has been shown to support the undifferentiated state of hESCs 
with no chromosomal changes and abnormalities. (Ojala 2009) 
The studied feeder-free culture method in this thesis was very sensitive. 
Especially during the first few passages, there were quite many differentiated areas, 
which needed to be removed in order to maintain the culture pure. The low quality of 
the cultures in the beginning might be due to inappropriate cell seeding density. Thus, in 
the beginning of feeder-free cultures, a great number of cells are required to start up a 
pure and healthy culture. Also, during the time of the experimental works, the stem cell 
lines under investigation were performing quite poorly. Hence, it is understandable that 
the resulting feeder-free cultures suffered and struggled in the beginning. The time 
window for passaging hPSCs was very narrow. Therefore, the cultures needed close 
inspection daily. The cell density and distribution of colonies also had an affect on the 
purity and pluripotency of the colonies. Too sparse or dense cultures resulted in 
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differentiated areas. The outgrowth of fibroblast-like cells was detected in all cell lines 
during the first few passages of stem cells in 2D feeder-free cultures. These fibroblast-
like cells have been also previously detected in hESC colonies cultured in feeder-free 
conditions. (Stojkovic et al. 2005; Wang et al. 2005; Ojala 2009)   
Out of the three stem cell lines studies, hESC line Regea 08/023 and hiPSC line 
FiPS 5-7 proliferated nicely after the lag phase in the beginning. Unfortunately, the 
hESC 06/040 line survived rather poorly in feeder-free cultures, and these cells were 
only maintained, not proliferated in feeder-free conditions. The poor success of 06/040 
cell line can result from the bad outperformance of the line in general during the time of 
the experimental work. Some hESC lines have also been reported to have poor survival 
when passaged enzymatically (Li et al. 2009). Addition of ROCK inhibitor to the 
culture media might increase the cloning efficiency of hESCs in enzymatically passaged 
cultures. The Regea 08/023 and FiPS 5-7 feeder-free cultures were pure and the 
colonies clear-lined and spherical. There were much less differentiated areas detected in 
the later passages. Both of these lines expressed pluripotency markers after 8 passages 
in feeder-free conditions. Despite, more detailed and thorough analysis on gene 
expression level should be conducted in order to evaluate the pluripotency of the 
investigated lines than conducted in this experiment. Moreover, more detailed 
investigations are required before conclusions can be drawn about the suitability of 
specific lines for feeder-free conditions. 
Feeder-free culture system with mTeSR®1 medium and MatrigelTM offers a 
culture solution which takes the culture of stem cells towards xeno-free and defined 
culture systems. Even though the mTeSR®1 the feeder-free culture system is fully 
defined, it includes animal protein sources in the culture media and it is combined with 
animal-based MatrigelTM, which in fact, makes it a non xeno-free method. (Ludwig et 
al. 2006b) However, new human-derived counterparts for MatrigelTM have been 
developed and are commercially available. The use of these human-based ECM 
components would remove one animal-based component from the feeder-free culture 
systems. After the lag phase in the beginning of feeder-free cultures, the maintenance of 
these cells was rather convenient. In a feeder-free culture system, there is no cultivation 
and maintenance of the feeder cell population, and the enzymatic passaging of these 
cells in the feeder-free conditions was relatively fast and easy compared to the 
conventional mechanical passaging of stem cells on feeders. An effective feeder-free 
culture method without any animal-based components could provide a more convenient 
and cost effective culture system alternative for conventional stem cell cultures on 
feeder cells. However, more detailed and profound comparison of the effectiveness and 
costs between conventional culture system on feeders and feeder-free culture systems 
should be carried out.  
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7.3. Attachment and proliferation of hPSCs on 
microparticles 
The attachment and proliferation of hESCs on microparticles have been studied on 
several different particle types (Crook et al. 2008; Fernandes et al. 2009; Leung et al. 
2009; Lock et al. 2009; Nie et al. 2009; Oh et al. 2009; Storm et al. 2010; Chen et al. 
2011). In this thesis, the attachment and proliferation of Regea 08/023 and FiPS 5-7 
lines were investigated on self-prepared PLLA particles of two sizes and commercial 
DE 53 microparticles in feeder-free culture conditions. The self-prepared PLGA 
particles were not chosen for the cell culture studies due to their immense 
autofluorescence and background. The effect of different cell to particle ratios, 
agitation, and well-plate sizes in cell attachment to these particles were tested. The 
attachment and proliferation of investigated stem cell lines were evaluated by 
immunofluorescence stainings.  
 The cells attached poorly on the self-prepared PLLA particles of both sizes. 
Furthermore, the cells did not proliferate during the 7-day culture time on 
microparticles. There was no difference in cell attachment and proliferation between the 
smaller and larger PLLA particles. However, the smallest particles were rarely seen 
when analysing the results. They were probably lost during the immunofluorescence 
protocol due to their small size and slow sedimentation to the bottom of the tube or they 
were trapped inside the EB-like cell clusters. The smaller spherical particles have larger 
surface area to volume ratio. Therefore, similar cell to particle ratios used in sell ceeding 
should result in higher yields with the smaller particles due to the increased surface 
area. However, too small particles size has been shown to result in aggregate formation 
(Chen et al. 2011). To investigate the effects of size more thoroughly, more controlled 
shapes and size distributions of microparticles are needed.  
In this study, the few cells visualized on the investigated PLLA particles were 
attached as spot-like small clusters or as single cells on microparticles. In fact, the cell 
attachment on these biodegradable particles was quite similar to the attachment of the 
ECM coatings. It is possible that the cells were able to attach only to the coated areas on 
particle surfaces. Therefore, poor coating success might have resulted in low cell 
attachment and proliferation. However, the overlapping of the coating and cells should 
be verified by immunostaining.  
Based on this study, hPSCs do not prefer PLLA microparticles as a culture 
substrate. This might be due to the rather hydrophobic nature of the particle surfaces. 
Furthermore, there might have been solvent residuals left in the prepared particles, 
which might have been toxic for the cells. However, PLGA microparticles, which were 
prepared with similar preparation protocol and residual removal as done in this study, 
supported the attachment of neural stem cells (Bible et al. 2009). Nevertheless, more 
thorough purification of the particles after preparation is in order to ensure the purity of 
the particles. For example, Thomson et al. incubated blended PLLA and PLGA particles 
prepared with similar single emulsion method overnight in 70 % ethanol to remove the 
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solvent residuals (Thomson et al. 2010). In addition to solvent residuals, the acidic 
degradation products of PLLA might have disturbed the growth of the sensitive hESCs. 
However, the culture time in this experiment was rather short during which the 
degradation of PLLA should not be meaningful.  
 In contrast to the PLLA microparticles, hPSCs attached and proliferated well on 
the commercial DE 53 microparticles. Cellulose is quite hydrophilic material due to the 
many hydroxyl groups in its molecular structure. The hydrophilic nature of DE 53 
microparticles in combination with positively charged surface might have increased the 
cell attachment. These results are in line with the results of other research groups 
investigating maintenance of hESCs on DE 53 particles in feeder-free conditions. (Oh et 
al. 2009; Leung et al. 2010) However, the findings in this study were based on 
immunofluoresrence stainings, and therefore, they are not quantitative. The analysis of 
cell proliferation should be verified for example by cell counts or by comparing the 
amounts of RNA between two timepoints. Commercial cell proliferation assay kits 
provide an alternative method for measuring cell proliferation, as well. The DE 53 
microparticle culture system seemed to be suitable for maintaining hPSCs in 
undifferentiated state. Most of the cells expressed a plurimarker after 6 to 7 days in 
microparticle cultures. However, the visualization of the plurimarker proved to be 
extremely challenging due to the strong background and autofluorescence of the 
particles. Therefore, other methods for the analysis of the pluripotency should be 
applied. For instance, fluorescence activated cell sorting (FACS) and RT-PCR have 
been used for analysing the pluripotency of hESCs on DE 53 particles. (Oh et al. 2009) 
Furthermore, in this experiment, only few plurimarkers were examined. Solely feeder-
free conditions have shown to be prone for genetic alterations and abnormalities for 
hESCs (Ludwig et al. 2006a). This in combination with a 3D growth substratum with 
strong positive charge can result in an environment which exposes the cultures for 
genetic alterations or induces differentiation of hPSCs. Therefore, the cells cultured in 
these conditions should be karyotyped and their teratoma formation capability should 
also be checked in the future.  
 The cell to particle ratio had a huge impact on the cell attachment and 
proliferation. The more cells were seeded relative to microparticles, the more cells 
attached and proliferated. In cultures with too sparse cell density, the cells lack essential 
cell-to-cell interactions and the amount of secreted growth factors is minor, which might 
have led to worse cell proliferation in cultures with smaller cell to particle ratio. 
Therefore, initial parameters for microparticle cultures have significant influence on the 
cell attachment and proliferation efficacy and require optimization in future studies. 
Addition of ROCK inhibitor to the culture medium might have improved the cell 
attachment and proliferation. Increased cell survival of hESCs in microparticle cultures 
with ROCK has been reported (Storm et al. 2010). 
 The major advantage of the microparticles is their large surface area compared 
to the 2D cultures. In this study, the absence of continuos agitation allowed the particles 
to settle down to the bottom the well. This decreased the available surface area for cell 
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attachment. The particles also settled quite tightly, which might have led to the 
formation of concentration gradients and inefficient gas-liquid oxygen transfer. Thus, 
the absence of continuos agitation decreases the factors considered to be advantages of 
microparticle culture systems. In order to fully utilize the potential of microparticle 
culture system, continuos agitation is most likely required. In this study, the effect of 
agitation during cell seeding on cell attachment was investigated. The agitation did not 
have an influence on the amount of attached cells. Instead, in cultures with agitation, the 
cells were more evenly distributed on the particles. In addition, there was less and 
smaller aggregates in cultures with agitation. These results are similar to previously 
reported by Storm and his colleagues for mESCs in microparticle cultures. (Storm et al. 
2010) Agitation in microparticle cultures causes fluid flow in the culture flasks. In 
large-scale cultures, such as in spinner flasks and bioreactors, the forces caused by the 
continuos agitation are significant and might induce signalling responses in the cultured 
cells. For example, the agitation has been shown to induce differentiation of hESCs in 
microparticle cultures (Leung et al. 2010). Thus, the effects of agitation should be 
investigated more thoroughly, and a broader comparison between cell lines should be 
conducted. 
 Different parameters of microparticles and microparticle culture conditions have 
not yet been thoroughly studied. Among these is the shape of the microparticles. In this 
study, microparticles of two different shapes, cylindrical and spherical, were tested, but 
the influence of the shape on cell attachment and proliferation was not evaluated. 
However, it was noticed that the cells gathered between DE 53 particles that had 
adhered together. The elongated shape of the cylindrical DE 53 microparticles might 
promote adhesion of microparticles, because these particles have more surface area 
where the adhesion can take place compared to spherical particles. Similar aggregate 
formation with cylindrical particles in hESC cultures has been reported (Chen et al. 
2011). The importance of microparticle shape might be emphasized in agitated large-
scale cultures. The shape of the particle might influence on the shear stress that the cells 
experience, because cylindrical microparticles are anisotropic. The cells on different 
sides of the cylindrical microparticles in agitated cultures might experience the shear 
stress with different forces resulting in more heterogenous culture conditions, whereas 
in spherical ones the shear stress affecting the cells would presumably be more 
homogenous.  
 In this thesis, the hPSCs were cultured on microparticles for a very short period. 
After 6 to 7 days in microparticle cultures, the DE 53 particles had a great number of 
cells growing on them, but the particles were not fully confluent yet. Furthermore, the 
yields of proliferating stem cells on microparticles were not properly compared to the 
2D cultures. Thus, nothing can be concluded about the efficacy and long-term effects of 
microparticle culture system compared to the conventional culture systems based on this 
study. Despite, the success of culturing hESCs on DE 53 particles in feeder-free 
conditions has been shown also in long-term studies (Oh et al. 2009). In addition, the 
culture systems in this experiment were very small, whereas the most promising results 
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of maintaining hESCs on microparticles have been detected in large-scale cultures, such 
as spinner flasks and bioreactors. (Oh et al. 2009; Storm et al. 2010; Fernandes et al. 
2009) In these studies, 2 to 4 fold yields compared to the conventional 2D cultures have 
been reached in short periods. Thus, the microparticle culture systems might be more 
efficient in large-scale culture systems. 
The cell attachment, distribution and proliferation in this study were evaluated 
by immunofluorescence staining. Besides the autofluorescence and background with 
DAPI, secondary antibodies and phalloidin also disturbed the analysis of cells on 
microparticles. Furthermore, the microparticles are 3D structures, with cells growing 
around the particles. In immunofluorescence imaging, these 3D structures were 
attempted to be converted into 2D images. Obviously, plenty of information was lost 
while imaging of these 3D stuctures by conventional fluorescence microscopy, and most 
of the visualized cells were out of focus. In addition, the 3D structure of investigated 
microparticles became a problem when plating them between objective and coverage 
glass for the visualization of the immunofluorescence analysis. Especially the PLLA 
particles were so thick that huge amount of mounting media with DAPI was required. 
This resulted in increased background during the imaging. Therefore, more practical 
imaging methods appropriate for 3D structures, such as confocal microscopy, should be 
investigated and further developed. 
Based on this thesis, and similar results from the literature, the commercial DE 
53 microparticles seem suitable for maintaining and proliferating hPSCs in feeder-free 
conditions, whereas the self-prepared PLLA microparticles do not support the 
attachment and proliferation of hPSCs. However, more thorough characterization and 
long-term culture of the cells in microparticle suspension cultures should be conducted. 
Furthermore, building and designing a large-scale microparticle culture system with 
continuos agitation could result in huge yields of undifferentiated hPSCs. This system 
could provide a potential and cost-effective cell source for research purposes and tissue 
engineering applications.  Despite the suitability of DE 53 microparticles for in vitro 
applications, they are not potential candidates for transplantation purposes due to their 
non-biodegradable nature. In contrast, the PLLA microparticles offer the advantage of 
being biodegradable and allow incorporation of therapeutic agents or growth factors 
inside and can function as PAMs. These characteristics would be beneficial both in vitro 
and in vivo tissue engineering applications. Therefore, an effort to increase the cell 
attachment and proliferation of hPSCs on these PLLA microparticles should be carried 
out. 
7.4. Differentiation of hPSCs into RPEs on microparticles 
The current differentiation protocols for RPE differentiation from hPSCs are inefficient 
and result in very small yields of mature RPE. Moreover, in these protocols, the 
differentiation is spontaneous, not directed. (Klimayanska et al. 2004; Lund et al. 2006; 
Vugler et al. 2008; Idelson et al. 2009; Meyer et al. 2009) Therefore, there is a demand 
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for more effective differentiation protocols. Microparticles have been utilised in 
maintenance and proliferation of hESCs in suspension cultures, but only few studies 
have reported differention of hESCs towards mature cell types. (Phillips et al. 2008; 
Lock et al. 2009; Lecina et al. 2010; Leung et al. 2010) In this study, the capability and 
efficiency of stem cells to differentiate towards RPE cells on microparticles was 
investigated. The differentiation of hPSCs into RPE cells in microparticle culture 
system has not been previously reported in the literature.  
Due to the poor cell attachment on PLLA particles, solely the suitability of 
commercial DE53 particles for differentiation of Regea 08/023 and FiPS 5-7 into RPE 
cells was tested. The hESC line 06/040 was left out from differentiation studies due to 
its poor performance in feeder-free culture conditions and cell attachment experiments. 
The investigated cells were adapted in feeder-free cultures for 8 passages after which 
they were seeded onto MatrigelTM coated microparticles. After two days of culturing 
microparticles in mTeSR® 1 media, the RPE differentiation media DM- was changed to 
the cells. 
The appearance of pigmentation is considered to be a sign of RPE differentiation 
and maturation. (Burke et al. 2008; Gamm et al. 2008) The first pigmented areas in both 
investigated cell lines were detected on day 15 after starting the differentiation protocol. 
The pigmented cell clusters were clearly on the surfaces of the particles. The appearance 
of pigmentation was quite similar compared to the conventional differentiation protocol 
in use in our group. Thus, the differentiation of hPSCs into RPE cells is not accelerated 
by microparticle culture conditions compared to the conventional EB culture method 
(Vaajasaari et al. 2011). During the differentiation, the number of pigmented areas on 
both lines increased. However, the pigmented cell clusters were small. After 35 days in 
differentiation media, 10 to 15 small pigmented areas were seen. The amount of 
pigmented cells was not larger compared to the conventional differentiation protocol 
(Vaajasaari et al. 2011). These conclusions are based only on visual estimation of the 
amount of pigment in the cultures, which is objective and not quantitative data.   
During the differentiation, the particles started to aggregate, and cell bridges 
started to grow between the small aggregates. After five weeks in differentiation, these 
aggregates had formed EB-like structures, which did not detach. The aggregation and 
formation of these EB-like structures might have had influence on the differentiation. 
Therefore a constant agitation of the particles in long-term cultures would be beneficial 
for preventing the clustering of particles. The formation of EB-like structures in hESC 
microparticle culture systems has been reported previously with high cell seeding ratios. 
(Lock et al. 2009) Indeed, the cell to particle ratio in the differentiation experiment was 
rather high. The seeded cells probably proliferated in such amounts, that the beads 
became confluent, and there was no substrata for all the cells where attach to. In a recent 
study, the commercial DE53 particles became confluent of hESCs in mTeSR® 1 feeder-
free culture conditions on day 6. (Oh et al. 2009) The cell to particle ratio used in the 
study in question was 1.5-fold compared to seeding ratio used in this experiment. 
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Besides a constant agitation, passaging of cells onto fresh particles might decrease the 
formation of EB-like structures.  
In addition to observing the appearance of pigmentation, the differentiation was 
investigated on gene expression level. The RT-PCR analysis showed that both 
investigated cell lines expressed RPE maturation markers bestrophin and MITF. Thus, 
both hESCs and hiPSCs differentiate into RPE cells on commercial DE 53 
microparticles. The bands visualised in gel electrophoresis were quite weak, especially 
for the bestrophin, but they were still visible. Interestingly, the pluripotent control 
sample of undifferentiated hiPSCs also expressed MITF. This might be due to the hFFs 
on which the control sample was grown. The expression of MITF in human fibroblast 
cells has been previously reported (Semov et al. 2002). The RT-PCR is a qualitative 
analysis method, which reveals which genes are expressed in the investigated samples. 
However, it does not reveal anything about the expression levels of the genes. 
Therefore, in order to evaluate the effectiveness of the differentiation in microparticle 
culture system, quantitative analysis such as quantitative RT-PCR should be carried out.  
Based on this experiment, hPSCs can differentiate to RPE cells in microparticle 
suspension cultures. However, it seems that the differentiation efficacy is not increased 
when compared to the conventional culture method during the first five weeks. 
(Vaajasaari et al. 2011) More thourough investigations are required before final 
conclusions can be drawn regarding the differentiation efficacy. As the differentiation 
on conventional EB-cultures, the differentiation on microparticles seems to be 
spontaneous. The development and maturation of RPE is a rather slow process, both in 
vivo and in vitro. (Klimayanska et al. 2004; Vugler et al. 2007) Thus, a long-term effect 
of differentiation of stem cells towards RPE in microparticle culture systems on the 
resulting yields should be investigated. Even though the microparticles seem not to have 
an influence on the differentiation in short-term, they might result in increased yields in 
long-term studies.  
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8. CONCLUSIONS 
The traditional culture methods of hPSCs prevent their production in large-scale and are 
expensive and laborious. Therefore, novel culture methods are constantly being 
searched. Furthermore, the current differentiation protocols for RPE cells from hESCs 
are inefficient resulting in low amounts of cells available for research purposes. The aim 
of this thesis was to investigate if self-prepared biodegradable PLGA and PLLA and 
commercial DE 53 microparticles could be utilised in increasing the efficacy of RPE 
differentiation from hPSCs. In addition, the suitability of microparticles for hPSC 
maintenance in feeder-free culture conditions was investigated. No previously published 
data exists about RPE differentiation in microparticle suspension cultures from stem 
cells. 
 Self-prepared PLLA microparticles did not support the attachment and 
proliferation of hPSCs in feeder free conditions. The PLGA microparticles were not 
included in cell culture studies due to their enormous autofluorescence characteristic. 
The poor performance of PLLA particles in cell culture studies is probably due to the 
hydrophobicity of the particle surfaces, which hinders the attachment of ECM coatings 
and cells. However, these PLLA particles are biodegradable and offer the advantage of 
incorporation and controlled release of pharmacologically active agents, which makes 
these particles attractive for tissue engineering applications. Thus, effort should be made 
in order to increase the cell attachment on these particles.  
 In contrast to PLLA microparticles, the commercial DE 53 particles supported 
the growth of hPSCs in feeder-free culture conditions in short-term studies. 
Furthermore, the hPSCs were successfully differentiated into RPE cells on these DE 53 
particles. However, the differentiation efficacy in these microparticle suspension 
cultures was not increased compared to the conventional differentiation protocols during 
the five-week experiment time. Nevertheless, the long-term outcome of the 
differentiation on microparticles should be investigated in the future. 
 The analysis of cell attachment and proliferation on microparticles is 
complicated by the immense autofluorescence of the particles as well as background 
with secondary antibodies and DAPI. Furthermore, the 3D structure of the particles 
prevents their proper analysis with conventional immunofluorescence protocols and 
microscopy. Therefore, novel methods for characterization and imaging of cells on 
microparticles should be developed.  
 Microparticles are far from being routinely used in hPSC maintenance and 
proliferation. However, at the moment they seem appealing and promising with 
possibilities to grow stem cells in large-scale and cost effectively. This thesis confirmed 
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the previously reported suitability of commercial DE 53 microparticles for the 
maintenance and proliferation of hPSCs. Moreover, this was the first study in which 
hPSCs were successfully differentiated into RPE cells on microparticles. However, the 
effectiveness of the differentiation in microparticle suspension cultures did not rise 
above the conventional differentiation protocols, at least in based on these preliminary 
short-term studies.  
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